MAD2L2 (also known as REV7 or MAD2B) is a HORMA domain-containing adapter protein with dual essential roles in DNA damage response. It functions as: (1) an accessory subunit of DNA polymerase zeta (Pol zeta), mediating translesion DNA synthesis by bridging the catalytic REV3L subunit with REV1 to bypass DNA lesions; and (2) a core component of the shieldin complex (SHLD1/SHLD2/SHLD3/REV7), which acts downstream of 53BP1-RIF1 to suppress DNA end resection, thereby promoting NHEJ over homologous recombination. The HORMA domain adopts open and closed conformations that enable high-affinity binding to partner proteins via a "safety-belt" mechanism. MAD2L2 also regulates cell cycle progression by inhibiting the APC/C through binding to CDH1 and CDC20. Biallelic loss causes Fanconi anemia complementation group V.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005634
nucleus
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: REV7/MAD2L2 localizes to the nucleus where it performs its core functions in DNA damage response (translesion synthesis and DSB repair) and cell cycle regulation. Multiple studies confirm nuclear localization (PMID:11717438, PMID:17541814, PMID:17719540).
Reason: Nuclear localization is well-established and consistent with REV7's roles in DNA polymerase zeta-mediated TLS and shieldin complex-mediated DSB repair.
Supporting Evidence:
PMID:11717438
the mitotic checkpoint protein MAD2B interacts with PRCC
PMID:17541814
HCCA2 and MAD2L2 also colocalized in the nucleus of Hela cells
|
|
GO:0006281
DNA repair
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: REV7 participates in DNA repair through multiple mechanisms: (1) as part of Pol zeta for translesion synthesis to bypass DNA lesions, and (2) as part of shieldin complex to regulate DSB repair pathway choice.
Reason: DNA repair is a core function of REV7. The IBA annotation appropriately captures the general DNA repair role supported by extensive literature.
Supporting Evidence:
PMID:29656893
Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection and in sensitizing BRCA1-deficient cells to PARP inhibitors
PMID:20164194
we show that the REV7-mediated interactions are responsible for DNA damage tolerance
PMID:27500492
identified REV7 as a previously undescribed FA gene, which we term FANCV
|
|
GO:0016035
zeta DNA polymerase complex
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: REV7 is an essential accessory subunit of DNA polymerase zeta. The minimal complex (Pol-zeta2) consists of REV3L and REV7; the fully active complex (Pol-zeta4) includes REV3L, REV7, POLD2, and POLD3.
Reason: REV7 as a component of Pol zeta is one of its core, evolutionarily conserved functions from yeast to humans.
Supporting Evidence:
PMID:24449906
The purified four-subunit Pol zeta4 (Rev3-Rev7-PolD2-PolD3) is much more efficient and more processive
PMID:11485998
Human REV7 (hREV7) was also cloned, and its product was found to interact with hREV3, but the biological function of hREV7 remained unknown
file:human/MAD2L2/MAD2L2-deep-research-falcon.md
REV7 is an accessory subunit of human Pol zeta together with the catalytic subunit REV3L and replicative subunits POLD2/POLD3; Pol zeta functions as the extender polymerase in translesion synthesis
|
|
GO:0005634
nucleus
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Electronic annotation based on UniProt subcellular location. Consistent with experimental evidence.
Reason: The IEA annotation is redundant with the IBA annotation but correctly reflects the experimentally verified nuclear localization of REV7.
Supporting Evidence:
PMID:17541814
HCCA2 and MAD2L2 also colocalized in the nucleus of Hela cells
|
|
GO:0005694
chromosome
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: REV7 is recruited to chromosomes, particularly at sites of DNA double-strand breaks during G1 and S phase as part of the shieldin complex.
Reason: Chromosome localization is consistent with REV7's role in the shieldin complex for DSB repair.
Supporting Evidence:
PMID:29656893
Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Some cytoplasmic localization has been observed for REV7, though its primary functional localizations are nuclear.
Reason: Cytoplasmic localization has been reported and is consistent with UniProt annotation, though nucleus is the primary site of function.
Supporting Evidence:
PMID:17719540
the Shigella effector IpaB, when delivered into epithelial cells, causes cell-cycle arrest by targeting Mad2L2
|
|
GO:0005819
spindle
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: REV7 localizes to the mitotic spindle through interaction with CHAMP1 and RAN, reflecting its role in cell cycle regulation.
Reason: Spindle localization has been experimentally demonstrated and reflects REV7's secondary role in mitotic regulation.
Supporting Evidence:
PMID:21063390
CAMP localizes to chromosomes and the spindle including kinetochores
|
|
GO:0006281
DNA repair
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: Electronic annotation based on UniProt keyword mapping. Correctly reflects REV7's role in DNA repair.
Reason: Redundant with IBA annotation but correct. DNA repair is a well-established core function of REV7.
Supporting Evidence:
PMID:29656893
Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection
|
|
GO:0006351
DNA-templated transcription
|
IEA
GO_REF:0000043 |
KEEP AS NON CORE |
Summary: REV7 modulates transcription through interaction with TCF4/TCF7L2 and the JNK-ELK1 pathway, but this is not a core function.
Reason: Transcriptional regulation by REV7 is documented but represents a secondary pleiotropic effect rather than a core molecular function.
Supporting Evidence:
PMID:19443654
Thus, MAD2B is a novel TCF4-interacting protein
PMID:17296730
hRev7 acts to promote Elk-1 phosphorylation by the c-Jun N-terminal protein kinase (JNK) MAP kinases
|
|
GO:0006974
DNA damage response
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: REV7 is a key component of the DNA damage response through both TLS and DSB repair pathway choice.
Reason: DNA damage response is accurately captured by this annotation. REV7 coordinates multiple aspects of cellular response to DNA damage.
Supporting Evidence:
PMID:17296730
our data linking hRev7 to gene expression changes suggest that hRev7 has a widespread role in coordinating the cellular response to DNA damage
|
|
GO:0010717
regulation of epithelial to mesenchymal transition
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: REV7 negatively regulates EMT through its interaction with TCF4, which modulates E-cadherin expression.
Reason: EMT regulation by REV7 is documented experimentally but represents a secondary pleiotropic function mediated through TCF4 interaction, not a core function.
Supporting Evidence:
PMID:19443654
Knockdown of MAD2B in SW480 colorectal cancer cells led to the conversion of epithelial cells to a mesenchymal fibroblastoid phenotype
|
|
GO:0051301
cell division
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: REV7 regulates cell division through inhibition of the APC/C and spindle-related functions.
Reason: Cell division regulation is a core function of REV7 through its inhibition of APC/C activators CDH1 and CDC20.
Supporting Evidence:
PMID:11459826
MAD2B inhibits both CDH1-APC and CDC20-APC
|
|
GO:0005515
protein binding
|
IPI
PMID:10527948 Evidence for an interaction of the metalloprotease-disintegr... |
MARK AS OVER ANNOTATED |
Summary: Interaction with ADAM9 (MDC9) demonstrated by yeast two-hybrid and confirmed biochemically.
Reason: "Protein binding" is uninformative. The interaction with ADAM9 lacks clear functional significance and may be an artifact of Y2H screening.
Supporting Evidence:
PMID:10527948
a novel MAD2-related protein, MAD2beta, as a binding partner of the MDC9 cytoplasmic domain
|
|
GO:0005515
protein binding
|
IPI
PMID:10531379 Interaction of the metalloprotease disintegrins MDC9 and MDC... |
MARK AS OVER ANNOTATED |
Summary: Another study on MDC9/ADAM9 interactions.
Reason: "Protein binding" is uninformative for functional annotation purposes.
Supporting Evidence:
PMID:10527948
a novel MAD2-related protein, MAD2beta, as a binding partner of the MDC9 cytoplasmic domain
|
|
GO:0005515
protein binding
|
IPI
PMID:11277934 Trichosanthin interacts with acidic ribosomal proteins P0 an... |
MARK AS OVER ANNOTATED |
Summary: Interaction with trichosanthin demonstrated.
Reason: "Protein binding" is uninformative. Trichosanthin interaction lacks clear physiological relevance.
Supporting Evidence:
PMID:10527948
a novel MAD2-related protein, MAD2beta, as a binding partner of the MDC9 cytoplasmic domain
|
|
GO:0005515
protein binding
|
IPI
PMID:17719540 A bacterial effector targets Mad2L2, an APC inhibitor, to mo... |
MARK AS OVER ANNOTATED |
Summary: Interaction with Shigella IpaB protein that modulates APC activity.
Reason: "Protein binding" is uninformative. The interaction with bacterial effector IpaB is relevant for pathogenesis but not normal cellular function.
Supporting Evidence:
PMID:17719540
the Shigella effector IpaB, when delivered into epithelial cells, causes cell-cycle arrest by targeting Mad2L2
|
|
GO:0005515
protein binding
|
IPI
PMID:21063390 CAMP (C13orf8, ZNF828) is a novel regulator of kinetochore-m... |
MARK AS OVER ANNOTATED |
Summary: Interaction with CHAMP1 demonstrated, relevant to spindle function.
Reason: "Protein binding" is uninformative. This interaction is functionally relevant but should be captured by more specific terms related to spindle function.
Supporting Evidence:
PMID:21063390
CAMP localizes to chromosomes and the spindle including kinetochores
|
|
GO:0005515
protein binding
|
IPI
PMID:22828282 The C-terminal domain of human Rev1 contains independent bin... |
MARK AS OVER ANNOTATED |
Summary: Interaction with REV3L demonstrated by structural and biochemical studies.
Reason: "Protein binding" is uninformative. The REV7-REV3L interaction is a core function but should be captured by the Pol zeta complex annotation.
Supporting Evidence:
PMID:20164194
REV7 interacts with both REV3 and REV1 polymerases
|
|
GO:0005515
protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network. |
MARK AS OVER ANNOTATED |
Summary: High-throughput interactome study.
Reason: "Protein binding" from high-throughput studies lacks functional context.
Supporting Evidence:
PMID:20164194
REV7 interacts with both REV3 and REV1 polymerases
|
|
GO:0005515
protein binding
|
IPI
PMID:26496610 A human interactome in three quantitative dimensions organiz... |
MARK AS OVER ANNOTATED |
Summary: Quantitative interactome study.
Reason: "Protein binding" from high-throughput studies lacks functional context.
Supporting Evidence:
PMID:20164194
REV7 interacts with both REV3 and REV1 polymerases
|
|
GO:0005515
protein binding
|
IPI
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
MARK AS OVER ANNOTATED |
Summary: Interaction with shieldin complex components (SHLD2, SHLD3) demonstrated.
Reason: "Protein binding" is uninformative. These interactions are functionally critical and should be captured by process annotations for DSB repair.
Supporting Evidence:
PMID:29656893
We identified a novel vertebrate-specific protein complex, shieldin, comprising REV7 plus three previously uncharacterized proteins
|
|
GO:0005515
protein binding
|
IPI
PMID:29789392 FAM35A associates with REV7 and modulates DNA damage respons... |
MARK AS OVER ANNOTATED |
Summary: Interaction with SHLD2/FAM35A demonstrated.
Reason: "Protein binding" is uninformative. Captured by shieldin complex function annotations.
Supporting Evidence:
PMID:29656893
We identified a novel vertebrate-specific protein complex, shieldin, comprising REV7 plus three previously uncharacterized proteins
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Binary protein interactome study.
Reason: "Protein binding" from high-throughput studies lacks functional context.
Supporting Evidence:
PMID:20164194
REV7 interacts with both REV3 and REV1 polymerases
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
MARK AS OVER ANNOTATED |
Summary: Neurodegenerative disease interactome study.
Reason: "Protein binding" from high-throughput studies lacks functional context.
Supporting Evidence:
PMID:20164194
REV7 interacts with both REV3 and REV1 polymerases
|
|
GO:0005654
nucleoplasm
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: Nucleoplasm localization demonstrated by immunofluorescence.
Reason: Nucleoplasm is a more specific localization consistent with REV7's nuclear functions in DNA repair.
Supporting Evidence:
PMID:17541814
HCCA2 and MAD2L2 also colocalized in the nucleus of Hela cells
|
|
GO:0042276
error-prone translesion synthesis
|
IDA
PMID:24449906 Human Pol ΞΆ purified with accessory subunits is active in tr... |
ACCEPT |
Summary: REV7 as part of Pol zeta participates in error-prone translesion synthesis to bypass DNA lesions.
Reason: This is a core function of REV7 as part of the DNA polymerase zeta complex. Error-prone TLS is the primary function of Pol zeta.
Supporting Evidence:
PMID:24449906
DNA polymerase zeta (Pol zeta) is a eukaryotic B-family DNA polymerase that specializes in translesion synthesis
|
|
GO:0005515
protein binding
|
IPI
PMID:20164194 Crystal structure of human REV7 in complex with a human REV3... |
MARK AS OVER ANNOTATED |
Summary: Crystal structure shows REV7 binding to REV3L and REV1.
Reason: "Protein binding" is uninformative. The specific adapter function is better captured by process annotations.
Supporting Evidence:
PMID:20164194
REV7 interacts with both REV3 and REV1 polymerases
|
|
GO:0090734
site of DNA damage
|
IDA
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
ACCEPT |
Summary: REV7 is recruited to sites of DNA damage as part of the shieldin complex.
Reason: Localization to DNA damage sites is consistent with REV7's role in the shieldin complex for DSB repair.
Supporting Evidence:
PMID:29656893
Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis
|
|
GO:0005515
protein binding
|
IPI
PMID:23143872 Structural insights into the assembly of human translesion p... |
MARK AS OVER ANNOTATED |
Summary: Structural study of translesion polymerase complex assembly.
Reason: "Protein binding" is uninformative. Captured by Pol zeta complex annotations.
Supporting Evidence:
PMID:20164194
we show the first crystal structure of human REV7 in complex with a fragment of human REV3 polymerase
|
|
GO:0019985
translesion synthesis
|
IDA
PMID:20164194 Crystal structure of human REV7 in complex with a human REV3... |
ACCEPT |
Summary: REV7 mediates translesion synthesis as an adapter in the Pol zeta complex.
Reason: This is a core function of REV7. The crystal structure and functional studies demonstrate REV7's essential role in TLS.
Supporting Evidence:
PMID:20164194
Our results highlight the function of REV7 as an adapter protein to recruit Polzeta to a lesion site
|
|
GO:0030674
protein-macromolecule adaptor activity
|
IDA
PMID:20164194 Crystal structure of human REV7 in complex with a human REV3... |
ACCEPT |
Summary: REV7 functions as an adapter protein bridging REV3L and REV1 in the Pol zeta complex.
Reason: This accurately captures REV7's molecular function. The HORMA domain mediates adapter function through safety-belt mechanism.
Supporting Evidence:
PMID:20164194
Our results highlight the function of REV7 as an adapter protein to recruit Polzeta to a lesion site
|
|
GO:0000122
negative regulation of transcription by RNA polymerase II
|
IDA
PMID:19443654 MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated... |
KEEP AS NON CORE |
Summary: REV7 negatively regulates TCF4-mediated transcription by preventing DNA binding.
Reason: This is a documented function but represents a secondary pleiotropic effect rather than a core molecular function of REV7.
Supporting Evidence:
PMID:19443654
Using the TOPFLASH reporter assay, we found that MAD2B blocks TCF4-mediated transactivation
|
|
GO:0003714
transcription corepressor activity
|
IMP
PMID:19443654 MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated... |
KEEP AS NON CORE |
Summary: REV7 acts as a transcription corepressor by inhibiting TCF4 DNA binding.
Reason: While experimentally demonstrated, transcription corepressor activity is a secondary function not directly related to REV7's core roles in DNA repair and cell cycle regulation.
Supporting Evidence:
PMID:19443654
Using the TOPFLASH reporter assay, we found that MAD2B blocks TCF4-mediated transactivation
|
|
GO:0000785
chromatin
|
NAS
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
ACCEPT |
Summary: REV7 associates with chromatin as part of the shieldin complex at DSB sites.
Reason: Chromatin association is consistent with REV7's role in DSB repair as part of the shieldin complex.
Supporting Evidence:
PMID:29656893
Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis
|
|
GO:0002208
somatic diversification of immunoglobulins involved in immune response
|
NAS
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
ACCEPT |
Summary: REV7 in the shieldin complex promotes immunoglobulin class-switch recombination.
Reason: CSR is a physiologically important function of the shieldin complex where REV7 is essential.
Supporting Evidence:
PMID:29656893
promotes NHEJ-dependent repair of intrachromosomal breaks, immunoglobulin class-switch recombination (CSR), and fusion of unprotected telomeres
|
|
GO:0035861
site of double-strand break
|
NAS
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
ACCEPT |
Summary: REV7 is recruited to DSB sites as part of the shieldin complex.
Reason: DSB site localization is consistent with shieldin complex function in suppressing DNA end resection.
Supporting Evidence:
PMID:29656893
Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis
|
|
GO:0043247
telomere maintenance in response to DNA damage
|
NAS
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
ACCEPT |
Summary: REV7 as part of shieldin promotes fusion of unprotected telomeres.
Reason: Telomere maintenance is a documented function of the shieldin complex.
Supporting Evidence:
PMID:29656893
promotes NHEJ-dependent repair of intrachromosomal breaks, immunoglobulin class-switch recombination (CSR), and fusion of unprotected telomeres
|
|
GO:2001034
positive regulation of double-strand break repair via nonhomologous end joining
|
NAS
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
ACCEPT |
Summary: REV7 in shieldin complex promotes NHEJ by suppressing DNA end resection.
Reason: This is a core function of REV7 as part of the shieldin complex.
Supporting Evidence:
PMID:29656893
Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection
|
|
GO:0005515
protein binding
|
IPI
PMID:34354233 ASTE1 promotes shieldin-complex-mediated DNA repair by atten... |
MARK AS OVER ANNOTATED |
Summary: Interaction with ASTE1 demonstrated.
Reason: "Protein binding" is uninformative. The ASTE1 interaction relates to shieldin function but should be captured by process terms.
Supporting Evidence:
PMID:29656893
We identified a novel vertebrate-specific protein complex, shieldin, comprising REV7 plus three previously uncharacterized proteins
|
|
GO:0005694
chromosome
|
IC
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
ACCEPT |
Summary: Inferred chromosome localization based on shieldin complex function.
Reason: Chromosome localization is consistent with REV7's role in DSB repair.
Supporting Evidence:
PMID:29656893
Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis
|
|
GO:0035861
site of double-strand break
|
IC
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
ACCEPT |
Summary: Inferred localization to DSB sites.
Reason: Consistent with shieldin complex function and experimental evidence.
Supporting Evidence:
PMID:29656893
Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis
|
|
GO:0045830
positive regulation of isotype switching
|
IDA
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
ACCEPT |
Summary: REV7 in shieldin complex is required for immunoglobulin class-switch recombination.
Reason: CSR regulation is a documented physiological function of the shieldin complex.
Supporting Evidence:
PMID:29656893
promotes NHEJ-dependent repair of intrachromosomal breaks, immunoglobulin class-switch recombination (CSR), and fusion of unprotected telomeres
|
|
GO:2000042
negative regulation of double-strand break repair via homologous recombination
|
IDA
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
ACCEPT |
Summary: REV7 in shieldin complex suppresses HR by inhibiting DNA end resection.
Reason: This is a core function of REV7. By promoting NHEJ, the shieldin complex antagonizes HR.
Supporting Evidence:
PMID:29656893
Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection
|
|
GO:2001034
positive regulation of double-strand break repair via nonhomologous end joining
|
IDA
PMID:29656893 DNA Repair Network Analysis Reveals Shieldin as a Key Regula... |
ACCEPT |
Summary: REV7 in shieldin complex promotes NHEJ.
Reason: This is a core function of REV7 as part of the shieldin complex.
Supporting Evidence:
PMID:29656893
Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-110311 |
ACCEPT |
Summary: Reactome pathway annotation for Pol zeta function in nucleoplasm.
Reason: Nucleoplasm localization is consistent with TLS and DSB repair functions.
Supporting Evidence:
PMID:24449906
DNA polymerase zeta (Pol zeta) is a eukaryotic B-family DNA polymerase that specializes in translesion synthesis
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-110322 |
ACCEPT |
Summary: Reactome pathway annotation for Pol zeta complex formation.
Reason: Consistent with REV7 function in Pol zeta.
Supporting Evidence:
PMID:24449906
At a minimum, Pol zeta consists of a catalytic subunit Rev3 and an accessory subunit Rev7
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-5652151 |
ACCEPT |
Summary: Reactome annotation for REV1 recruiting Pol zeta.
Reason: Consistent with TLS function.
Supporting Evidence:
PMID:20164194
Our results highlight the function of REV7 as an adapter protein to recruit Polzeta to a lesion site
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-5655835 |
ACCEPT |
Summary: Reactome annotation for POLK-REV1-POLZ complex.
Reason: Consistent with TLS function.
Supporting Evidence:
PMID:20164194
Our results highlight the function of REV7 as an adapter protein to recruit Polzeta to a lesion site
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-5655892 |
ACCEPT |
Summary: Reactome annotation for POLK nucleotide incorporation.
Reason: Consistent with TLS pathway.
Supporting Evidence:
PMID:24449906
DNA polymerase zeta (Pol zeta) is a eukaryotic B-family DNA polymerase that specializes in translesion synthesis
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-5655965 |
ACCEPT |
Summary: Reactome annotation for POLK-POLZ cooperation.
Reason: Consistent with TLS function.
Supporting Evidence:
PMID:24449906
The purified four-subunit Pol zeta4 (Rev3-Rev7-PolD2-PolD3) is much more efficient and more processive
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-5656105 |
ACCEPT |
Summary: Reactome annotation for POLI binding REV1 and PCNA.
Reason: Consistent with TLS pathway.
Supporting Evidence:
PMID:20164194
REV7 interacts with both REV3 and REV1 polymerases
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-5656148 |
ACCEPT |
Summary: Reactome annotation for POLI nucleotide incorporation.
Reason: Consistent with TLS pathway.
Supporting Evidence:
PMID:24449906
DNA polymerase zeta (Pol zeta) is a eukaryotic B-family DNA polymerase that specializes in translesion synthesis
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-HSA-5656158 |
ACCEPT |
Summary: Reactome annotation for POLZ elongation of POLI product.
Reason: Consistent with TLS function where REV7-containing Pol zeta extends.
Supporting Evidence:
PMID:24449906
The purified four-subunit Pol zeta4 (Rev3-Rev7-PolD2-PolD3) is much more efficient and more processive
|
|
GO:0005634
nucleus
|
IDA
PMID:19443654 MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated... |
ACCEPT |
Summary: Nuclear localization demonstrated experimentally.
Reason: Nuclear localization is well-established for REV7.
Supporting Evidence:
PMID:17541814
HCCA2 and MAD2L2 also colocalized in the nucleus of Hela cells
|
|
GO:0007015
actin filament organization
|
IMP
PMID:19443654 MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated... |
KEEP AS NON CORE |
Summary: REV7 knockdown affects actin organization as part of EMT phenotype.
Reason: This is an indirect effect through REV7's modulation of TCF4-mediated transcription, not a direct molecular function.
Supporting Evidence:
PMID:19443654
Mesenchymal induction was accompanied by F-actin redistribution and the appearance of a fibroblastoid phenotype
|
|
GO:0010719
negative regulation of epithelial to mesenchymal transition
|
IMP
PMID:19443654 MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated... |
KEEP AS NON CORE |
Summary: REV7 negatively regulates EMT by modulating TCF4 activity.
Reason: This is a secondary pleiotropic effect through TCF4 interaction.
Supporting Evidence:
PMID:19443654
Knockdown of MAD2B in SW480 colorectal cancer cells led to the conversion of epithelial cells to a mesenchymal fibroblastoid phenotype
|
|
GO:0010944
negative regulation of transcription by competitive promoter binding
|
IMP
PMID:19443654 MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated... |
KEEP AS NON CORE |
Summary: REV7 binding to TCF4 abolishes TCF4 DNA binding ability.
Reason: This mechanism explains how REV7 inhibits TCF4 function but is a secondary role.
Supporting Evidence:
PMID:19443654
TCF4 and MAD2B interactions abolished the DNA binding ability of TCF4
|
|
GO:0061629
RNA polymerase II-specific DNA-binding transcription factor binding
|
IPI
PMID:19443654 MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated... |
KEEP AS NON CORE |
Summary: REV7 binds to TCF4/TCF7L2 transcription factor.
Reason: This interaction is documented but represents a secondary function.
Supporting Evidence:
PMID:19443654
Thus, MAD2B is a novel TCF4-interacting protein
|
|
GO:0090090
negative regulation of canonical Wnt signaling pathway
|
IMP
PMID:19443654 MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated... |
KEEP AS NON CORE |
Summary: REV7 inhibits Wnt signaling by blocking TCF4 transcriptional activity.
Reason: This is an indirect effect through TCF4 inhibition, a secondary function.
Supporting Evidence:
PMID:19443654
Using the TOPFLASH reporter assay, we found that MAD2B blocks TCF4-mediated transactivation
|
|
GO:2000048
negative regulation of cell-cell adhesion mediated by cadherin
|
IMP
PMID:19443654 MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated... |
KEEP AS NON CORE |
Summary: REV7 knockdown affects E-cadherin expression through TCF4.
Reason: Indirect effect through TCF4 modulation.
Supporting Evidence:
PMID:19443654
MAD2B knockdown blocked E-cadherin expression
|
|
GO:0005515
protein binding
|
IPI
PMID:11717438 Impairment of MAD2B-PRCC interaction in mitotic checkpoint d... |
MARK AS OVER ANNOTATED |
Summary: Interaction with PRCC demonstrated.
Reason: "Protein binding" is uninformative. PRCC interaction has unclear functional significance.
Supporting Evidence:
PMID:11717438
the mitotic checkpoint protein MAD2B interacts with PRCC
|
|
GO:0005515
protein binding
|
IPI
PMID:17541814 Hepatocellular carcinoma-associated gene 2 interacts with MA... |
MARK AS OVER ANNOTATED |
Summary: Interaction with YY1AP1 demonstrated.
Reason: "Protein binding" is uninformative.
Supporting Evidence:
PMID:17541814
a novel HCCA2-interacting protein, MAD2L2
|
|
GO:0005634
nucleus
|
IDA
PMID:17541814 Hepatocellular carcinoma-associated gene 2 interacts with MA... |
ACCEPT |
Summary: Nuclear localization demonstrated.
Reason: Consistent with other studies showing nuclear localization.
Supporting Evidence:
PMID:17541814
HCCA2 and MAD2L2 also colocalized in the nucleus of Hela cells
|
|
GO:0005515
protein binding
|
IPI
PMID:11459826 MAD2B is an inhibitor of the anaphase-promoting complex. |
MARK AS OVER ANNOTATED |
Summary: Interaction with CDC20 and CDH1/FZR1 demonstrated.
Reason: "Protein binding" is uninformative. The functional consequence (APC inhibition) is captured by other annotations.
Supporting Evidence:
PMID:11459826
MAD2B inhibits both CDH1-APC and CDC20-APC. This inhibition is targeted to CDH1 and CDC20
|
|
GO:0042177
negative regulation of protein catabolic process
|
IDA
PMID:11459826 MAD2B is an inhibitor of the anaphase-promoting complex. |
ACCEPT |
Summary: REV7 inhibits APC-mediated protein degradation by binding CDH1/CDC20.
Reason: This captures the functional consequence of APC inhibition - prevention of ubiquitin-mediated protein degradation.
Supporting Evidence:
PMID:11459826
MAD2B also inhibits APC
PMID:11459825
MAD2L2 specifically binds and inhibits Cdh1-APC, paralleling the effect of MAD2 on Cdc20
|
|
GO:1904667
negative regulation of ubiquitin protein ligase activity
|
IDA
PMID:11459826 MAD2B is an inhibitor of the anaphase-promoting complex. |
ACCEPT |
Summary: REV7 inhibits APC/C ubiquitin ligase activity through CDH1/CDC20.
Reason: This is a core function of REV7 in cell cycle regulation.
Supporting Evidence:
PMID:11459826
MAD2B inhibits both CDH1-APC and CDC20-APC
|
|
GO:0005515
protein binding
|
IPI
PMID:17296730 Rev7/MAD2B links c-Jun N-terminal protein kinase pathway sig... |
MARK AS OVER ANNOTATED |
Summary: Interaction with ELK1 demonstrated.
Reason: "Protein binding" is uninformative. JNK binding term provides more specificity.
Supporting Evidence:
PMID:17296730
human Rev7 (hRev7)/MAD2B/MAD2L2 as an interaction partner for Elk-1
|
|
GO:0005680
anaphase-promoting complex
|
IDA
PMID:11459825 Inhibition of Cdh1-APC by the MAD2-related protein MAD2L2: a... |
ACCEPT |
Summary: REV7 colocalizes with the APC through interaction with CDH1.
Reason: Physical association with APC is consistent with REV7's role in APC inhibition.
Supporting Evidence:
PMID:11459825
MAD2L2 specifically binds and inhibits Cdh1-APC, paralleling the effect of MAD2 on Cdc20
|
|
GO:0008432
JUN kinase binding
|
IDA
PMID:17296730 Rev7/MAD2B links c-Jun N-terminal protein kinase pathway sig... |
KEEP AS NON CORE |
Summary: REV7 binds JNK kinases to facilitate ELK1 phosphorylation.
Reason: JNK binding is documented but represents a secondary signaling function.
Supporting Evidence:
PMID:17296730
hRev7 acts to promote Elk-1 phosphorylation by the c-Jun N-terminal protein kinase (JNK) MAP kinases
|
|
GO:0033138
positive regulation of peptidyl-serine phosphorylation
|
IDA
PMID:17296730 Rev7/MAD2B links c-Jun N-terminal protein kinase pathway sig... |
KEEP AS NON CORE |
Summary: REV7 promotes ELK1 serine phosphorylation through JNK pathway.
Reason: This is a secondary signaling function related to DNA damage response.
Supporting Evidence:
PMID:17296730
hRev7 acts to promote Elk-1 phosphorylation
|
|
GO:0042772
DNA damage response, signal transduction resulting in transcription
|
IDA
PMID:17296730 Rev7/MAD2B links c-Jun N-terminal protein kinase pathway sig... |
KEEP AS NON CORE |
Summary: REV7 links DNA damage to transcriptional changes through JNK-ELK1 pathway.
Reason: While related to DNA damage response, this signaling role is secondary to the core TLS and DSB repair functions.
Supporting Evidence:
PMID:17296730
hRev7 therefore contributes to the upregulation of Elk-1 target genes, such as egr-1, following exposure of cells to stress conditions caused by DNA-damaging agents
|
|
GO:0045893
positive regulation of DNA-templated transcription
|
IMP
PMID:17296730 Rev7/MAD2B links c-Jun N-terminal protein kinase pathway sig... |
KEEP AS NON CORE |
Summary: REV7 promotes transcription through ELK1 activation.
Reason: Secondary signaling function.
Supporting Evidence:
PMID:17296730
hRev7 therefore contributes to the upregulation of Elk-1 target genes
|
|
GO:0001558
regulation of cell growth
|
IGI
PMID:15988022 Multiple roles of vertebrate REV genes in DNA repair and rec... |
KEEP AS NON CORE |
Summary: REV gene disruption in chicken DT40 cells affects cell growth.
Reason: Cell growth regulation is an indirect consequence of REV7's roles in DNA repair and cell cycle control.
Supporting Evidence:
PMID:15988022
REV1-/- REV3-/- REV7-/- cells showed spontaneous cell death, chromosomal instability/fragility
|
|
GO:0006302
double-strand break repair
|
IGI
PMID:15988022 Multiple roles of vertebrate REV genes in DNA repair and rec... |
ACCEPT |
Summary: REV7 participates in DSB repair in vertebrate cells.
Reason: DSB repair is a core function of REV7 through the shieldin complex.
Supporting Evidence:
PMID:15988022
REV1-/- REV3-/- REV7-/- cells showed spontaneous cell death, chromosomal instability/fragility
PMID:29656893
Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection
|
|
GO:0016035
zeta DNA polymerase complex
|
IDA
PMID:20164194 Crystal structure of human REV7 in complex with a human REV3... |
ACCEPT |
Summary: Crystal structure demonstrates REV7 as part of the Pol zeta complex.
Reason: This is a core molecular function - REV7 as an essential subunit of Pol zeta.
Supporting Evidence:
PMID:20164194
we show the first crystal structure of human REV7 in complex with a fragment of human REV3 polymerase
|
|
GO:0005819
spindle
|
IDA
PMID:21063390 CAMP (C13orf8, ZNF828) is a novel regulator of kinetochore-m... |
ACCEPT |
Summary: REV7 localizes to spindle through CHAMP1 interaction.
Reason: Spindle localization is consistent with REV7's role in cell cycle regulation.
Supporting Evidence:
PMID:21063390
CAMP localizes to chromosomes and the spindle including kinetochores
|
|
GO:0005515
protein binding
|
IPI
PMID:20850016 Quantitative interaction proteomics and genome-wide profilin... |
MARK AS OVER ANNOTATED |
Summary: Interaction with POGZ demonstrated in epigenetic study.
Reason: "Protein binding" is uninformative.
Supporting Evidence:
PMID:20164194
REV7 interacts with both REV3 and REV1 polymerases
|
|
GO:0005515
protein binding
|
IPI
PMID:11485998 Interactions in the error-prone postreplication repair prote... |
MARK AS OVER ANNOTATED |
Summary: Interaction with REV1 and REV3 demonstrated.
Reason: "Protein binding" is uninformative. The functional consequence (TLS) is captured by process annotations.
Supporting Evidence:
PMID:11485998
The interaction between hREV1 and hREV7 was identified by the yeast two-hybrid library screening
|
|
GO:0007094
mitotic spindle assembly checkpoint signaling
|
TAS
PMID:10366450 Characterization of MAD2B and other mitotic spindle checkpoi... |
MARK AS OVER ANNOTATED |
Summary: MAD2L2 was originally identified as a MAD2 homolog with potential checkpoint function.
Reason: Despite the gene name (MAD2L2), REV7 does not function in the spindle assembly checkpoint like MAD2. The original characterization was based on sequence homology, not functional evidence. REV7's primary roles are in TLS and DSB repair.
Supporting Evidence:
PMID:10366450
we isolated a novel human gene, MAD2B (MAD2L2), which is homologous to the spindle checkpoint gene MAD2
PMID:11459826
Unlike MAD2, whose interaction with MAD1 is required for mitotic checkpoint control, MAD2B does not interact with MAD1
|
|
GO:0110027
negative regulation of DNA strand resection involved in replication fork processing
|
IMP
PMID:36075897 MAD2L2 promotes replication fork protection and recovery in ... |
NEW |
Summary: Beyond its shieldin role at double-strand breaks, MAD2L2/REV7 protects stalled/reversed replication forks by limiting MRE11-dependent nucleolytic resection of nascent DNA and promoting fork restart. This fork-protection activity is independent of shieldin and instead requires the Pol zeta partners REV3L and REV1.
Reason: Well-evidenced function (Paniagua et al. 2022, Nat Commun) not present in GOA or previously captured in this review. MAD2L2 depletion causes uncontrolled MRE11-dependent resection of stalled forks; fork protection is unaffected by loss of shieldin subunits but abolished by REV3L/REV1 loss, defining a distinct shieldin-independent, Pol zeta-associated fork-protection role. GO:0110027 is the correctly-branched biological-process term for negative regulation of resection during replication fork processing.
Supporting Evidence:
PMID:36075897
this function of MAD2L2 at replication forks is independent of its interaction with shieldin, but instead requires the TLS factors REV3L and REV1
PMID:36075897
uncontrolled MRE11-dependent resection of stalled forks
|
Q: How is REV7 partitioned between its roles in Pol zeta versus the shieldin complex?
Q: What determines whether REV7 functions in TLS versus DSB repair pathway choice?
Q: How does TRIP13/p31comet regulate REV7 complex disassembly?
Experiment: Structure-function analysis of REV7 mutants that selectively disrupt TLS versus shieldin functions
Hypothesis: Separation-of-function mutations can be identified that distinguish REV7's dual roles
Experiment: Live-cell imaging to track REV7 dynamics at DNA damage sites
Hypothesis: REV7 shows distinct recruitment kinetics to replication-associated versus DSB damage
Experiment: Characterization of REV7 post-translational modifications that regulate complex assembly
Hypothesis: Specific PTMs control whether REV7 assembles with Pol zeta or shieldin components
MAD2L2 (REV7/MAD2B/FANCV) is a HORMA-domain adaptor that uses a multivalent 'safety-belt' surface to bind structurally diverse partners and thereby coordinates DNA damage tolerance, double-strand break (DSB) repair pathway choice, and mitotic cell-cycle control [PMID:20164194, PMID:28887307, PMID:31484720]. In translesion synthesis, REV7 is the non-catalytic subunit of DNA polymerase zeta, binding the catalytic subunit REV3L through two short sequence motifs and recruiting REV1 via a distinct interface, with REV7 dimerization tethered by the two REV3 motifs being required for assembly of a functional REV1/pol zeta complex [PMID:20164194, PMID:22859296, PMID:25567983, PMID:30111544]; this activity underlies damage-induced mutagenesis and resistance to UV and crosslinking agents [PMID:3897794, PMID:25567983], and a point mutation (C70R) that severs the REV7βREV3 interaction abolishes damage tolerance and causes germ-cell loss and infertility PMID:24356953. REV7 is the central subunit of the shieldin complex (with SHLD1, SHLD2/FAM35A, SHLD3), which is recruited to DSBs and telomeres through the H4K20me2β53BP1βRIF1 axis and inhibits 5' end resection to enforce NHEJ over homologous recombination; its loss restores resection in BRCA1-deficient cells and causes PARP-inhibitor resistance [PMID:25799992, PMID:25799990, PMID:30046110, PMID:30154076, PMID:29160738]. Shieldin assembly depends on SHLD2-driven REV7 dimerization and on REV7's C-terminal wrapping around SHLD3, and is reversed by TRIP13-catalyzed closed-to-open conformational switching together with p31comet, which also disassembles the REV7βREV3 complex; competing seatbelt ligands such as CHAMP1 likewise tune this balance [PMID:31796627, PMID:31915374, PMID:33051298, PMID:34521823, PMID:36044844]. Independently of shieldin, REV7 protects and restarts stalled replication forks in a REV3L/REV1-dependent manner by limiting MRE11 resection PMID:36075897. In mitotic control, MAD2L2 inhibits both CDH1-APC and CDC20-APC by binding the activators rather than the core APC [PMID:11459826, PMID:11459825], and biallelic inactivating REV7 mutations cause Fanconi anemia (REV7 = FANCV) PMID:27500492.
| Year | Confidence | Finding | PMIDs | Journal |
|---|---|---|---|---|
| 1985 | High | REV7 (yeast ortholog) is required for UV-induced mutagenesis in Saccharomyces cerevisiae and belongs to the RAD6 epistasis group for UV survival, establishing its role in damage-induced mutagenesis. | PMID:3897794 | Molecular & general genetics |
| 1994 | Medium | Yeast REV7 gene was cloned and sequenced; its function is required for DNA damage-induced mutagenesis but is not essential for viability. | PMID:7871890 | Yeast |
| 1999 | Medium | Human MAD2B (MAD2L2) gene was isolated and characterized as homologous to the spindle checkpoint gene MAD2 (MAD2L1); chromosomal localization was determined (chromosome 1p36). | PMID:10366450 | Genomics |
| 2000 | Medium | Human REV7 (hREV7) interacts with hREV3 (catalytic subunit of DNA polymerase zeta) and with hMAD2 (but not hMAD1), establishing hREV7 as a component of the human pol zeta complex; interaction domains between hREV3 and hREV7 were determined. | PMID:10660610 | The Journal of biological chemistry |
| 2001 | High | MAD2B (MAD2L2) inhibits both CDH1-APC and CDC20-APC (anaphase-promoting complex) by targeting CDH1 and CDC20 directly, not APC itself; unlike MAD2, MAD2B does not interact with MAD1, indicating it relays a distinct cellular signal. | PMID:11459826 | Genes & development |
| 2001 | High | MAD2L2 specifically binds and inhibits CDH1-APC (but not CDC20-APC in contrast to MAD2); proposed mechanism is inhibition of substrate release from APC, paralleling MAD2's effect on CDC20. | PMID:11459825 | Genes & development |
| 2001 | Medium | MAD2B interacts with PRCC (papillary renal cell carcinoma protein); the PRCCTFE3 fusion protein retains the MAD2B interaction domain but this interaction is impaired, leading to mitotic checkpoint defects in t(X;1)-positive RCCs. | PMID:11717438 | Proceedings of the National Academy of Sciences |
| 2003 | Medium | Human REV1 and REV7 proteins form a stable heterodimer in solution; however, human REV7 does not influence the stability, substrate specificity, or kinetic parameters of REV1's transferase activity (negative finding for functional stimulation in humans, contrasting with yeast Rev7 stimulating Rev3). | PMID:12529368 | The Journal of biological chemistry |
| 2005 | Medium | In yeast, Rev1 forms a stable complex with Rev7 that copurifies; the polymerase-associated domain (PAD) of Rev1 mediates its binding to Rev7, revealing a novel protein-protein interaction role for the PAD. | PMID:16227619 | Molecular and cellular biology |
| 2007 | Medium | Human Rev7/MAD2B interacts with the transcription factor Elk-1 and promotes Elk-1 phosphorylation by JNK MAP kinases, thereby upregulating Elk-1 target gene expression (e.g., egr-1) following DNA damage. | PMID:17296730 | Molecular and cellular biology |
| 2007 | High | The Shigella effector IpaB binds directly to Mad2L2 and causes unscheduled APC activation (by neutralizing Mad2L2's APC-inhibitory function), leading to G2/M cell cycle arrest dependent on IpaB/Mad2L2 interaction, which promotes bacterial colonization. | PMID:17719540 | Cell |
| 2009 | Medium | MAD2B interacts with the small GTPase RAN throughout the cell cycle; during mitosis, they co-localize at the spindle; the interaction domain of RAN maps to a C-terminal 60 amino acid moiety, and MAD2B must be full-length. | PMID:19753112 | PloS one |
| 2009 | Medium | MAD2B interacts with TCF4; this interaction abolishes TCF4's DNA-binding ability and blocks TCF4-mediated transactivation; MAD2B knockdown leads to epithelial-mesenchymal transdifferentiation by de-repressing TCF4-mediated Slug expression. | PMID:19443654 | The Journal of biological chemistry |
| 2010 | High | Crystal structure of human REV7 in complex with a REV3 fragment (residues 1847-1898) was solved; the structure reveals the mechanism of REV7-REV3 interaction and shows that the REV7-REV3 interface creates a structural platform for REV1 binding, defining REV7 as an adaptor protein recruiting pol zeta to lesion sites. | PMID:20164194 | The Journal of biological chemistry |
| 2010 | Medium | Defined short sequence motifs in REV3 are necessary and sufficient for REV7 binding; MAD2 (MAD2L1) also binds the REV7-binding sequence in REV3, but REV7 does not bind the MAD2-binding sequences in MAD1 or CDC20, establishing distinct but overlapping short motif recognition between REV7 and MAD2. | PMID:20088965 | Genes to cells |
| 2010 | Medium | MAD2B interacts with clathrin light chain A (CLTA) during G2/M phase and co-localizes with CLTA at the mitotic spindle; MAD2B depletion causes CLTA redistribution away from the spindle and increased chromosome misalignment. | PMID:21152103 | PloS one |
| 2012 | High | Crystal structure of the ternary complex of human REV1 C-terminal domain, REV7, and a REV3 fragment was solved; the REV1 CTD uses a four-helix bundle to interact with REV7 via a conserved mammalian linker region, using a distinct interface from other TLS polymerase binding sites, providing the structural basis for pol zeta recruitment and polymerase switching. | PMID:22859296 | The Journal of biological chemistry |
| 2012 | High | NMR spectroscopy demonstrates that the Rev1 C-terminal domain uses independent interaction interfaces to simultaneously bind pol eta and REV7 (subunit of pol zeta), enabling Rev1 to serve as a scaffold accommodating multiple polymerases for TLS. | PMID:22828282 | FEBS letters |
| 2012 | Medium | REV7 is required for APC/C-mediated polyubiquitination and proteasomal degradation of REV1; REV7 depletion stabilizes REV1 by preventing its polyubiquitination, while REV7 overexpression augments REV1 degradation; the N-terminal region of REV1 contains both the APC degron and an additional REV7-binding domain. | PMID:23287467 | Cell cycle |
| 2013 | High | A missense mutation (C70R) in Rev7 disrupts its interaction with REV3 (catalytic subunit of pol zeta), causing infertility, primordial germ cell loss, increased apoptosis, S-phase arrest with DNA damage accumulation after mitomycin C; Rev7 C70R does not affect the mitotic spindle assembly checkpoint. | PMID:24356953 | The Journal of biological chemistry |
| 2013 | High | Mad2l2 is essential for primordial germ cell (PGC) maintenance in mice; Mad2l2-/- PGCs fail to arrest in G2 phase and fail to transition from H3K9me2 to H3K27me3 chromatin configuration; Mad2l2 interacts with histone methyltransferases G9a and GLP (downregulating H3K9me2) and inhibits Cdk1 (causing G2 arrest), which allows Ezh2 to upregulate H3K27me3. | PMID:24009519 | PLoS genetics |
| 2013 | High | REV7 is essential for primordial germ cell (PGC) maintenance and fertility in mice; Rev7-/- mice show progressive PGC loss during migration with increased apoptosis; DNA damage accumulation and increased histone methylation were detected in Rev7-/- embryos; REV7 is required for prevention of apoptotic cell death in PGCs. | PMID:23463509 | The Journal of biological chemistry |
| 2015 | High | REV7 (MAD2L2) loss in mouse and human cells re-establishes CTIP-dependent end resection of DSBs in BRCA1-deficient cells, restoring homologous recombination and causing PARP inhibitor resistance; REV7 is recruited to DSBs via the H2AX-MDC1-RNF8-RNF168-53BP1 chromatin pathway; REV7 promotes NHEJ by blocking HR and end resection downstream of 53BP1; ATM inhibition reverses PARPi resistance caused by REV7 loss. | PMID:25799992 | Nature |
| 2015 | High | MAD2L2 accumulates at uncapped telomeres and promotes NHEJ-mediated chromosome end fusion; MAD2L2 inhibits 5' end resection at DSBs and telomeres; its activity depends on ATM, RNF8, RNF168, 53BP1, and RIF1 but not PTIP, REV1, or REV3; MAD2L2 controls DSB repair independently of its TLS role. | PMID:25799990 | Nature |
| 2015 | High | REV7 is essential for DNA damage tolerance via its interaction with two distinct REV7-binding sites in mammalian REV3L (residues 1877-1887 and 1993-2003); mutation of both binding sites eliminates REV3L-REV7 interaction and fails to prevent spontaneous chromosome breaks or confer UV and cisplatin resistance. | PMID:25567983 | Nucleic acids research |
| 2015 | Medium | Rev7/Mad2B is required for functional mitotic spindle assembly; Rev7-depleted cells accumulate monoastral and abnormal spindles with misaligned chromosomes; Rev7 physically interacts with RAN and this interaction may mediate spindle organization; Rev7 depletion does not compromise spindle assembly checkpoint activity. | PMID:26697843 | Cell cycle |
| 2016 | High | Biallelic inactivating mutations in REV7 (FANCV) cause Fanconi anemia; patient-derived cells show increased chromosome breaks and G2/M accumulation upon crosslinking agents, Ξ³H2AX and 53BP1 foci; WT REV7 expression rescues normal phenotypes; CRISPR/Cas9 inactivation of REV7 in non-FA cells produces FA phenotype; REV7 is thereby identified as FANCV. | PMID:27500492 | The Journal of clinical investigation |
| 2017 | High | Crystal structures of MAD2L2 in complex with CAMP (chromosome alignment-maintaining phosphoprotein) fragments reveal that CAMP's 'WK' motif mediates binding to MAD2L2; the MAD2L2-CAMP interaction creates a distinct interface compared to REV3 binding; one crystal form shows a dimeric MAD2L2-CAMP structure with C-terminal domain swapping, providing evidence for the dynamic nature of MAD2L2 structure. | PMID:28887307 | The Journal of biological chemistry |
| 2017 | Medium | REV7 undergoes ubiquitin/proteasome-mediated degradation upon UV irradiation; the N-terminal destruction box of REV7 acts as the degron; Cul4A/B are the putative E3 ubiquitin ligases; HR23B physically interacts with and colocalizes with REV7 in nuclear foci post-UV and protects REV7 from accelerated degradation; degradation is NER-pathway dependent (observed with UV and 4-NQO but not cisplatin). | PMID:28440919 | The FEBS journal |
| 2018 | Medium | MAD2L2 (REV7) inhibits NCOA3 through a mechanism requiring p38 activation, which phosphorylates NCOA3 leading to its ubiquitination and proteasomal degradation; MAD2L2 was identified as an NCOA3 interaction partner by IP-MS. | PMID:29360267 | Molecular oncology |
| 2018 | High | 53BP1 cooperates with REV7 to promote NHEJ during class-switch recombination (CSR) but REV7 is not required for 53BP1-dependent V(D)J recombination; shieldin (comprising REV7, SHLD1/c20orf196, SHLD2/FAM35A, SHLD3/FLJ26957) was identified as a four-subunit complex essential for REV7-dependent DNA end protection and NHEJ in CSR but dispensable for REV7-dependent ICL repair. | PMID:30046110 | Nature |
| 2018 | High | SHLD2 (FAM35A) is a REV7 interactor identified by MS-based proteomics; FAM35A accumulates at DSBs in a 53BP1-, RIF1-, and REV7-dependent manner; FAM35A, REV7, and SHLD1 form a complex promoting NHEJ and limiting HR by antagonizing DNA end resection. | PMID:30154076 | The EMBO journal |
| 2018 | Medium | FAM35A (SHLD2) associates with REV7/RIF1/53BP1; FAM35A knockdown causes sensitivity to DNA-damaging agents; in BRCA1-mutant cells, FAM35A depletion increases resistance to camptothecin by allowing more efficient DNA end processing. | PMID:29789392 | The EMBO journal |
| 2018 | Medium | H4K20 dimethylation (H4K20me2) recruits the 53BP1-RIF1-MAD2L2 complex to DSBs; replication-associated 2-fold dilution of H4K20me2 promotes release of this complex and favors BRCA1 access; MAD2L2, like 53BP1 and RIF1, suppresses DSB accumulation of BRCA1. | PMID:29160738 | Cell cycle |
| 2018 | High | Rev7 dimerization is required for assembly and function of the Rev1/pol zeta TLS complex; Rev7 forms homodimers when tethered by the two RBMs of Rev3 and heterodimerizes with Mad2 and p31comet via the canonical HORMA dimerization interface; the Rev7 dimer binds only one copy of Rev1; mutation of the Rev7 dimer interface increases cellular sensitivity to DNA damage. | PMID:30111544 | Proceedings of the National Academy of Sciences |
| 2018 | Medium | Rev7 and 53BP1/Crb2 specifically repress long-range DSB resection through the RecQ helicase-dependent pathway (not Exo1), preventing hyper-resection in S. pombe; this mechanism is linked to PARPi resistance in BRCA1-deficient cells. | PMID:29697047 | eLife |
| 2019 | High | Crystal structures of REV7 in complex with RAN and IpaB fragments were solved; both RAN and IpaB bind the 'safety belt' region of REV7 causing rearrangement of the C-terminal beta-sheet; REV7 preferentially binds GTP-bound RAN, suggesting the RAN GTP/GDP switch regulates REV7 activity in cell cycle control. | PMID:31484720 | The Journal of biological chemistry |
| 2019 | High | Crystal structures of REV7 in complex with SHLD3's REV7-binding domain (RBD) were solved at 2.2-2.3 Γ ; SHLD3 uses an N-terminal loop and C-terminal alpha-helix for REV7 binding; the REV7 'safety belt' region retards RBD dissociation (low-nanomolar affinity); both structural elements are indispensable for high-affinity binding. | PMID:31796627 | The Journal of biological chemistry |
| 2020 | High | TRIP13 ATPase catalyzes the conversion of REV7 from an active 'closed' conformation to an inactive 'open' conformation, dissociating REV7-Shieldin to promote HDR; TRIP13 similarly disassembles the REV7-REV3 TLS complex, inhibiting error-prone TLS; TRIP13 overexpression confers PARPi resistance in BRCA1-deficient cancers. | PMID:31915374 | Nature cell biology |
| 2020 | Medium | p31comet binds the REV7-Shieldin complex, promotes REV7 inactivation (via TRIP13), causes dissociation from SHLD3, and promotes DNA end resection and PARPi resistance; p31comet also releases REV7 from REV3 in pol zeta, counteracting TLS. | PMID:33051298 | Proceedings of the National Academy of Sciences |
| 2020 | High | REV7 is required for B cell survival upon AID-deamination independently of its roles in DSBR, G2/M transition, or REV1-mediated TLS; REV7-dependent TLS across UNG-processed apurinic/apyrimidinic (AP) sites is required for cell survival upon AID/APOBEC deamination. | PMID:32499490 | Nature communications |
| 2021 | High | MAD2L2 dimerization (mediated by SHLD2) accelerates MAD2L2-SHLD3 interaction and is required for shieldin complex assembly and NHEJ function; MAD2L2 wraps its C-terminus around SHLD3 creating a stable complex; appropriate TRIP13 levels are important for proper shieldin (dis)assembly. | PMID:34521823 | Nature communications |
| 2022 | Medium | CHAMP1 binds directly to REV7 via the REV7 seatbelt/C-terminal domain (competing with SHLD3), reduces shieldin complex levels, increases DSB end resection, and activates HR repair; CHAMP1 also interacts with POGZ in a heterochromatin complex promoting HR; CHAMP1 overexpression confers PARPi resistance. | PMID:36044844 | Cell reports |
| 2022 | High | MAD2L2 promotes replication fork protection and restart independently of shieldin; MAD2L2 loss leads to uncontrolled MRE11-dependent resection of stalled forks and ssDNA accumulation; fork protection by MAD2L2 requires REV3L and REV1 (TLS partners) but not shieldin subunits. | PMID:36075897 | Nature communications |
| 2022 | Medium | CDH1 interacts with MAD2L2 using the same C-terminal residues that REV1 uses (Rev1-like binding pattern); MAD2L2's C-terminus interface is essential for both CDH1-MAD2L2 binding and MAD2L2 homodimerization. | PMID:32811646 | Biochemical and biophysical research communications |
| 2024 | Medium | REV7 binds directly to p53 and blocks ATM-dependent p53 Ser15 phosphorylation; REV7 is also involved in p53 destabilization, revealing a novel function of REV7 in DSB-induced p53 signaling. | PMID:38557443 | Cell cycle |
| 2024 | Medium | AURKB interacts with and modulates expression of MAD2L2 in bladder cancer cells; AURKB knockdown effects (suppression of proliferation/migration, cell cycle arrest, senescence) are rescued by MAD2L2 overexpression, placing MAD2L2 downstream of AURKB in a DDR pathway affecting p53. | PMID:38515112 | Journal of translational medicine |
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan and verification summary
- Objective 1 (identity/domain verification): Completed. Human MAD2L2 encodes REV7/MAD2B (UniProt Q9UI95), a 211-aa HORMA-domain protein whose C-terminus forms a conformational βsafety-beltβ that entraps partner peptides; it can homo- and hetero-dimerize. These defining features align with UniProt annotations and recent literature on human REV7/MAD2L2 (URLs: https://doi.org/10.1080/15384101.2024.2333227, Feb 2024; https://doi.org/10.3389/fonc.2024.1516165, Jan 2025) (biller2024rev7p53interactioninhibits pages 1-3, maggs2025rev7asmall pages 1-2).
Comprehensive research report: MAD2L2 (REV7/MAD2B; UniProt Q9UI95)
1) Key concepts and definitions
- Identity and domain architecture: MAD2L2 (REV7/MAD2B; also FANCV) is a human HORMA-domain protein (~211 aa) with a C-terminal βsafety-beltβ region that shifts between open/closed states to encircle short partner motifs (consensus ΟΟxPxxxpP). REV7 forms homo- and hetero-dimers; dimerization underlies several functions (TLS and DSB repair), whereas some mitotic roles are partly dimerization-independent. URLs: Cell Cycle (Feb 2024) https://doi.org/10.1080/15384101.2024.2333227; Frontiers in Oncology (Jan 2025) https://doi.org/10.3389/fonc.2024.1516165 (biller2024rev7p53interactioninhibits pages 1-3, maggs2025rev7asmall pages 1-2, maggs2025rev7asmall pages 2-4).
- Canonical complexes: (i) DNA polymerase ΞΆ (Pol ΞΆ): REV7 is an accessory subunit of human Pol ΞΆ together with the catalytic subunit REV3L and replicative subunits POLD2/POLD3; Pol ΞΆ functions as the βextenderβ polymerase in translesion synthesis (TLS). (ii) Shieldin: REV7 is core to the SHLD1/SHLD2/SHLD3 complex that acts downstream of 53BP1 to limit 5β² end resection, favoring classical NHEJ over HR at double-strand breaks (DSBs). URLs: Cell Cycle 2024 https://doi.org/10.1080/15384101.2024.2333227; IJMS 2023 https://doi.org/10.3390/ijms242115799 (biller2024rev7p53interactioninhibits pages 1-3, vassel2023rev7monomeris pages 1-2, vassel2023rev7monomeris pages 2-4).
- Structural mechanism: The HORMA βsafety-beltβ creates high-affinity, topologically entrapped complexes with partner RBMs (e.g., in REV3L and SHLD3). Remodeling by the AAA+ ATPase TRIP13 (with p31comet) can open the seat-belt to disassemble REV7 complexes (Pol ΞΆ or shieldin). URL: Frontiers in Oncology 2025 https://doi.org/10.3389/fonc.2024.1516165 (maggs2025rev7asmall pages 2-4, maggs2025rev7asmall pages 25-26).
2) Recent developments and latest research (2023β2024 prioritized)
- Dimerization-dependent functions and repair pathway activities (2023): A non-dimerizing Rev7 mutant (K44A/R124A/A135D) is unable to support gap-filling TLS, cannot reconstitute resistance to ionizing radiation or alkylating agents, fails to restore olaparib response, and loses shieldin interactions (e.g., SHLD2 binding); however, it retains partial mitotic functions via RAN interaction. Published Oct 31, 2023 (IJMS). URL: https://doi.org/10.3390/ijms242115799 (vassel2023rev7monomeris pages 1-2, vassel2023rev7monomeris pages 2-4).
- New DDR signaling role via p53 (2024): REV7 directly binds p53 and inhibits ATM-mediated p53 Ser15 phosphorylation, adding a signaling-layer role independent of 53BP1. REV7 loss increased etoposide-induced p53 S15 phosphorylation roughly two-fold; reconstitution experiments and localization assays support direct REV7βp53 regulation. Published Feb 9, 2024 (Cell Cycle). URL: https://doi.org/10.1080/15384101.2024.2333227 (biller2024rev7p53interactioninhibits pages 1-3, biller2024rev7p53interactioninhibits pages 12-13).
- Contemporary synthesis of REV7 biology (2025 review, summarizing 2018β2024 advances): Highlights REV7βs centrality in TLS (REV1βPol ΞΆ βmutasomeβ), DSB pathway choice via shieldin, and cell-cycle control; details safety-belt entrapment, RBM consensus, TRIP13/p31comet remodeling, and emerging translational strategies (e.g., small-molecule targeting of REV1βREV7 assembly to suppress mutagenic TLS). URL: https://doi.org/10.3389/fonc.2024.1516165 (maggs2025rev7asmall pages 1-2, maggs2025rev7asmall pages 20-21, maggs2025rev7asmall pages 25-26).
3) Primary molecular functions, complexes, localization, and pathway context
- Translesion synthesis (TLS): REV7 is an accessory subunit of Pol ΞΆ and functionally couples with REV1 to extend from nucleotides inserted opposite lesions by Y-family polymerases. Dimerization of REV7 is required for Rev1βPol ΞΆ assembly and TLS gap filling; REV7 loss or dimerization-defective variants abrogate TLS activity in cellular assays. URLs: IJMS (Oct 2023) https://doi.org/10.3390/ijms242115799; Frontiers in Oncology (Jan 2025) https://doi.org/10.3389/fonc.2024.1516165 (vassel2023rev7monomeris pages 1-2, vassel2023rev7monomeris pages 2-4, maggs2025rev7asmall pages 1-2).
- DSB repair pathway choice (NHEJ vs HR) and shieldin: REV7 in shieldin constrains 5β² end resection, promoting 53BP1-dependent classical NHEJ and antagonizing HR. Loss of REV7/shieldin increases HR, impacts class switch recombination, and modulates responses to PARP inhibition. URLs: Cell Cycle (Feb 2024) https://doi.org/10.1080/15384101.2024.2333227; IJMS (Oct 2023) https://doi.org/10.3390/ijms242115799 (biller2024rev7p53interactioninhibits pages 1-3, vassel2023rev7monomeris pages 1-2, vassel2023rev7monomeris pages 2-4).
- Replication fork protection and replication stress responses: REV7 contributes to fork stability and genome maintenance; shieldin-dependent and -independent activities have been reported. Dimerization is required for several of these functions. URL: IJMS (Oct 2023) https://doi.org/10.3390/ijms242115799 (vassel2023rev7monomeris pages 1-2, vassel2023rev7monomeris pages 2-4).
- Cell-cycle/checkpoint roles: Beyond DNA repair, REV7 modulates mitosis by interacting with RAN and restraining APC/C activation via CDH1 sequestration; the non-dimerizing mutant partially rescues micronuclei formation and G2/M accumulation, indicating separable mitotic functions. URL: IJMS (Oct 2023) https://doi.org/10.3390/ijms242115799 (vassel2023rev7monomeris pages 1-2, vassel2023rev7monomeris pages 2-4).
- DNA damage signaling integration via p53: REV7 is now shown to directly suppress ATMβp53 phosphorylation at Ser15, linking REV7 to checkpoint signal modulation. URL: Cell Cycle (Feb 2024) https://doi.org/10.1080/15384101.2024.2333227 (biller2024rev7p53interactioninhibits pages 1-3, biller2024rev7p53interactioninhibits pages 12-13).
- Subcellular localization: REV7 accumulates at DNA damage sites and colocalizes with 53BP1; nuclear functions are evident in TLS foci and DSB repair compartments. URL: Cell Cycle (Feb 2024) https://doi.org/10.1080/15384101.2024.2333227 (biller2024rev7p53interactioninhibits pages 1-3).
4) Interactions and regulatory network
- Core interactors: REV3L (two RBMs on REV3L bind REV7), REV1 (mutasome assembly), SHLD3/SHLD2/SHLD1 (shieldin), 53BP1 (pathway context), RAN (mitotic role), and CDH1 (APC/C regulation). URLs: Cell Cycle 2024 https://doi.org/10.1080/15384101.2024.2333227; IJMS 2023 https://doi.org/10.3390/ijms242115799; Frontiers in Oncology 2025 https://doi.org/10.3389/fonc.2024.1516165 (biller2024rev7p53interactioninhibits pages 1-3, vassel2023rev7monomeris pages 1-2, vassel2023rev7monomeris pages 2-4, maggs2025rev7asmall pages 1-2, maggs2025rev7asmall pages 2-4).
- New/expanded interactions (2024): Direct REV7βp53 binding inhibits ATM-dependent phosphorylation of p53 (Ser15), showing REV7 as a negative regulator of p53 activation under DSB-inducing stress. URL: Cell Cycle (Feb 2024) https://doi.org/10.1080/15384101.2024.2333227 (biller2024rev7p53interactioninhibits pages 1-3, biller2024rev7p53interactioninhibits pages 12-13).
- Remodeling and disassembly: TRIP13 with p31comet can open the REV7 safety-belt to remodel complexes (Pol ΞΆ, shieldin), influencing TLS and NHEJ choice. URL: Frontiers in Oncology (Jan 2025) https://doi.org/10.3389/fonc.2024.1516165 (maggs2025rev7asmall pages 2-4, maggs2025rev7asmall pages 25-26).
5) Pathway integration (FA/BRCA, TLS, NHEJ/HR)
- FA pathway link: REV7 has been referred to as FANCV and participates in interstrand crosslink repair in concert with FA/BRCA factors; mechanistic links include its TLS role (Pol ΞΆ) and shieldin-mediated pathway choice. URL: Cell Cycle (Feb 2024) https://doi.org/10.1080/15384101.2024.2333227 (biller2024rev7p53interactioninhibits pages 1-3).
- TLS coordination: REV1βPol ΞΆ mutasome assembly and function depend on REV7βs dimerization and seat-belt-mediated RBM recognition. URL: IJMS (Oct 2023) https://doi.org/10.3390/ijms242115799; Frontiers in Oncology (Jan 2025) https://doi.org/10.3389/fonc.2024.1516165 (vassel2023rev7monomeris pages 1-2, vassel2023rev7monomeris pages 2-4, maggs2025rev7asmall pages 1-2).
- DSB pathway choice: By restraining 5β² end resection, shieldin/REV7 promotes classical NHEJ and antagonizes HR; this axis underlies responses to PARP inhibitors in BRCA1-defective contexts and broader DSB repair outcomes. URL: Cell Cycle (Feb 2024) https://doi.org/10.1080/15384101.2024.2333227 (biller2024rev7p53interactioninhibits pages 1-3, biller2024rev7p53interactioninhibits pages 12-13).
6) Disease relevance, applications, and quantitative data
- Cancer biology and therapeutic modulation: REV7 expression is associated with adverse outcomes across multiple malignancies and contributes to therapy resistance by supporting TLS and NHEJ. Suppressing REV7/Pol ΞΆ or disrupting REV1βREV7 can sensitize cells to DNA-damaging chemotherapy (e.g., cisplatin) and modulate PARP inhibitor responses; a small-molecule (JH-RE-06) that blocks REV1βREV7 assembly suppresses mutagenic TLS and sensitizes cells to cisplatin in preclinical studies. URL: Frontiers in Oncology (Jan 2025) https://doi.org/10.3389/fonc.2024.1516165 (maggs2025rev7asmall pages 20-21, maggs2025rev7asmall pages 1-2).
- PARP inhibitor (PARPi) response phenotypes: REV7 loss increases HR and can confer PARPi resistance in some contexts; conversely, proper shieldin/REV7 function supports NHEJ and PARPi sensitivity in BRCA1-defective settings. Functionally, REV7β/β cells display altered responses to olaparib that are reversed by wild-type REV7 but not by a non-dimerizing mutant, linking REV7 dimerization to therapeutic response. URLs: IJMS (Oct 2023) https://doi.org/10.3390/ijms242115799; Cell Cycle (Feb 2024) https://doi.org/10.1080/15384101.2024.2333227 (vassel2023rev7monomeris pages 1-2, vassel2023rev7monomeris pages 2-4, biller2024rev7p53interactioninhibits pages 1-3).
- DDR signaling quantitative example (2024): In REV7β/β cells, etoposide-induced p53 Ser15 phosphorylation was increased approximately two-fold relative to controls; re-expression of REV7 suppressed this signal, indicating a direct regulatory effect. Published Feb 9, 2024. URL: https://doi.org/10.1080/15384101.2024.2333227 (biller2024rev7p53interactioninhibits pages 1-3).
7) Subcellular context and localization
- Nuclear DNA repair foci: REV7 localizes to DNA damage sites, colocalizing with 53BP1 in DSB repair foci; in TLS, it associates with replication-associated lesions via the REV1βPol ΞΆ mutasome at chromatin/replication compartments. URL: Cell Cycle (Feb 2024) https://doi.org/10.1080/15384101.2024.2333227 (biller2024rev7p53interactioninhibits pages 1-3).
- Mitosis: REV7 contributes to spindle assembly and APC/C regulation through RAN and CDH1 interactions; some mitotic functions persist even when dimerization/TLS functions are impaired, indicating separable structural requirements. URL: IJMS (Oct 2023) https://doi.org/10.3390/ijms242115799 (vassel2023rev7monomeris pages 1-2, vassel2023rev7monomeris pages 2-4).
8) Expert opinions and synthesis from recent authoritative sources
- 2024 primary study (Cell Cycle): Establishes a direct, mechanistically supported signaling role for REV7 in inhibiting ATMβp53 activation, with quantitative evidence and genetic separation from 53BP1, refining REV7βs position at the intersection of repair and checkpoint signaling (Feb 2024). URL: https://doi.org/10.1080/15384101.2024.2333227 (biller2024rev7p53interactioninhibits pages 1-3, biller2024rev7p53interactioninhibits pages 12-13).
- 2023 primary study (IJMS): Demonstrates that HORMA-mediated dimerization is essential for REV7βs TLS and DSB repair roles but not for all mitotic functions, clarifying how structural states partition REV7βs pleiotropic activities (Oct 2023). URL: https://doi.org/10.3390/ijms242115799 (vassel2023rev7monomeris pages 1-2, vassel2023rev7monomeris pages 2-4).
- 2025 synthesis (Frontiers review): Integrates 2018β2024 evidence across TLS, shieldin/NHEJ, safety-belt/RBM biophysics, and translational targeting (e.g., REV1βREV7 inhibitors), providing comprehensive, current context (Jan 2025). URL: https://doi.org/10.3389/fonc.2024.1516165 (maggs2025rev7asmall pages 1-2, maggs2025rev7asmall pages 20-21, maggs2025rev7asmall pages 25-26).
Limitations and notes
- The report emphasizes 2023β2024 primary sources and a 2025 integrative review. Earlier foundational shieldin/NHEJ papers (e.g., 2015 Nature) are referenced within the 2024 study and review; the Cell Cycle 2024 article provides the most direct, recent citations and mechanistic updates (biller2024rev7p53interactioninhibits pages 1-3, biller2024rev7p53interactioninhibits pages 12-13). Where specific quantitative statistics are available (e.g., ~2Γ increase in p53 Ser15 phosphorylation upon REV7 loss), they are included.
Conclusion
MAD2L2 (REV7/MAD2B; Q9UI95) is a human HORMA-domain adaptor whose safety-belt/dimerization mechanics underlie assembly of Pol ΞΆ for TLS and the shieldin complex for DSB pathway choice. Recent work adds a direct role in checkpoint signaling via p53, and functional dissection shows dimerization is essential for repair/TLS but not all mitotic functions. These properties position REV7 as a key integrator of lesion bypass, DSB repair choice (NHEJ vs HR), replication stress tolerance, and DDR signaling, with growing translational interest in modulating REV7/REV1βPol ΞΆ to influence therapy responses. URLs: 2024 Cell Cycle https://doi.org/10.1080/15384101.2024.2333227; 2023 IJMS https://doi.org/10.3390/ijms242115799; 2025 Frontiers in Oncology https://doi.org/10.3389/fonc.2024.1516165 (biller2024rev7p53interactioninhibits pages 1-3, vassel2023rev7monomeris pages 1-2, maggs2025rev7asmall pages 1-2).
References
(biller2024rev7p53interactioninhibits pages 1-3): Megan Biller, Sara Kabir, Chkylle Boado, Sarah Nipper, Alexandra Saffa, Ariella Tal, Sydney Allen, Hiroyuki Sasanuma, Didier DrΓ©au, Cyrus Vaziri, and Junya Tomida. Rev7-p53 interaction inhibits atm-mediated dna damage signaling. Cell Cycle, 23:339-352, Feb 2024. URL: https://doi.org/10.1080/15384101.2024.2333227, doi:10.1080/15384101.2024.2333227. This article has 5 citations and is from a peer-reviewed journal.
(maggs2025rev7asmall pages 1-2): Lara R. Maggs and Mitch McVey. Rev7: a small but mighty regulator of genome maintenance and cancer development. Frontiers in Oncology, Jan 2025. URL: https://doi.org/10.3389/fonc.2024.1516165, doi:10.3389/fonc.2024.1516165. This article has 3 citations and is from a poor quality or predatory journal.
(maggs2025rev7asmall pages 2-4): Lara R. Maggs and Mitch McVey. Rev7: a small but mighty regulator of genome maintenance and cancer development. Frontiers in Oncology, Jan 2025. URL: https://doi.org/10.3389/fonc.2024.1516165, doi:10.3389/fonc.2024.1516165. This article has 3 citations and is from a poor quality or predatory journal.
(vassel2023rev7monomeris pages 1-2): Faye M. Vassel, Daniel J. Laverty, Ke Bian, Cortt G. Piett, Michael T. Hemann, Graham C. Walker, and Zachary D. Nagel. Rev7 monomer is unable to participate in double strand break repair and translesion synthesis but suppresses mitotic errors. International Journal of Molecular Sciences, 24:15799, Oct 2023. URL: https://doi.org/10.3390/ijms242115799, doi:10.3390/ijms242115799. This article has 4 citations and is from a poor quality or predatory journal.
(vassel2023rev7monomeris pages 2-4): Faye M. Vassel, Daniel J. Laverty, Ke Bian, Cortt G. Piett, Michael T. Hemann, Graham C. Walker, and Zachary D. Nagel. Rev7 monomer is unable to participate in double strand break repair and translesion synthesis but suppresses mitotic errors. International Journal of Molecular Sciences, 24:15799, Oct 2023. URL: https://doi.org/10.3390/ijms242115799, doi:10.3390/ijms242115799. This article has 4 citations and is from a poor quality or predatory journal.
(maggs2025rev7asmall pages 25-26): Lara R. Maggs and Mitch McVey. Rev7: a small but mighty regulator of genome maintenance and cancer development. Frontiers in Oncology, Jan 2025. URL: https://doi.org/10.3389/fonc.2024.1516165, doi:10.3389/fonc.2024.1516165. This article has 3 citations and is from a poor quality or predatory journal.
(biller2024rev7p53interactioninhibits pages 12-13): Megan Biller, Sara Kabir, Chkylle Boado, Sarah Nipper, Alexandra Saffa, Ariella Tal, Sydney Allen, Hiroyuki Sasanuma, Didier DrΓ©au, Cyrus Vaziri, and Junya Tomida. Rev7-p53 interaction inhibits atm-mediated dna damage signaling. Cell Cycle, 23:339-352, Feb 2024. URL: https://doi.org/10.1080/15384101.2024.2333227, doi:10.1080/15384101.2024.2333227. This article has 5 citations and is from a peer-reviewed journal.
(maggs2025rev7asmall pages 20-21): Lara R. Maggs and Mitch McVey. Rev7: a small but mighty regulator of genome maintenance and cancer development. Frontiers in Oncology, Jan 2025. URL: https://doi.org/10.3389/fonc.2024.1516165, doi:10.3389/fonc.2024.1516165. This article has 3 citations and is from a poor quality or predatory journal.
Performed a conservative quality-assurance pass on the existing, complete review
(79 existing_annotations, 3 core_functions). No substantive changes were made β
the review was found to be biologically and curatorially sound.
uv run ai-gene-review validate --verbose --terms genes/human/MAD2L2/MAD2L2-ai-review.yaml β β Valid.scripts/run_reference_validator.sh) β all validations passed.supporting_text quotes are verbatim substrings of theprotein binding (GO:0005515): all 22 instances are MARK_AS_OVER_ANNOTATEDcore_functions, so downgrading the genericcore_functions:--terms validation).KEEP_AS_NON_CORE or accepted as secondary.description field: clean standalone biology, no project/curation framing.supported_by quotes (PMID:11717438supporting_text (PMID:17719540 IpaB β cell-cycleMARK_AS_OVER_ANNOTATED is the conservative call; a case could be made for strongerprotein binding interactions of clear functional import (REV3L/REV1:MODIFY β GO:0030674; left as MARK_AS_OVER_ANNOTATED to avoid duplicating theConclusion: review passes QA; no edits required.
Reconciled the Affinage deep-research record (run 2026-06-10, 47 PMIDs, self-eval win)
against the QA'd review. Most Affinage PMIDs were already cited/adjudicated. Two genuine
gaps were filled conservatively; no existing decision was weakened.
description asserted the FANCV identity but had no citationreferences (reference_review HIGH / VERIFIED) and attachedsupported_by on the existing GO:0006281 DNA repair (IBA) annotation.references (HIGH / VERIFIED) and captured as one NEW annotation: GO:0110027 "negativesupported_by quotes attached.Validation after edits: uv run ai-gene-review validate genes/human/MAD2L2/MAD2L2-ai-review.yaml
β β Valid. Evaluation write-up: projects/AFFINAGE_EVALUATION/results/fa-cohort/MAD2L2.md.
Deliberately NOT imported (conservative): Affinage's coarse mechanism_profile GO layer
(including an unsupported GO:0003677 DNA binding), and mouse-PGC / regulation-of-MAD2L2 /
single-group recent human findings (e.g. TRIP13-p31comet disassembly, CHAMP1 competition,
p53 signaling) β real but peripheral to the human core functions.
id: Q9UI95
gene_symbol: MAD2L2
aliases:
- REV7
- MAD2B
- FANCV
- hREV7
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
MAD2L2 (also known as REV7 or MAD2B) is a HORMA domain-containing adapter protein
with dual essential roles in DNA damage response. It functions as: (1) an accessory
subunit of DNA polymerase zeta (Pol zeta), mediating translesion DNA synthesis by
bridging the catalytic REV3L subunit with REV1 to bypass DNA lesions; and (2) a
core component of the shieldin complex (SHLD1/SHLD2/SHLD3/REV7), which acts downstream
of 53BP1-RIF1 to suppress DNA end resection, thereby promoting NHEJ over homologous
recombination. The HORMA domain adopts open and closed conformations that enable
high-affinity binding to partner proteins via a "safety-belt" mechanism. MAD2L2
also regulates cell cycle progression by inhibiting the APC/C through binding to
CDH1 and CDC20. Biallelic loss causes Fanconi anemia complementation group V.
core_functions:
- molecular_function:
id: GO:0030674
label: protein-macromolecule adaptor activity
description: >-
REV7/MAD2L2 is an essential accessory subunit of DNA polymerase zeta that mediates
translesion DNA synthesis. It bridges REV3L (the catalytic subunit) with REV1,
enabling bypass of DNA lesions during replication. This adapter function requires
REV7 dimerization and the HORMA domain safety-belt mechanism.
directly_involved_in:
- id: GO:0019985
label: translesion synthesis
in_complex:
id: GO:0016035
label: zeta DNA polymerase complex
supported_by:
- reference_id: PMID:20164194
supporting_text: "Our results highlight the function of REV7 as an adapter protein to recruit Polzeta to a lesion site"
- reference_id: PMID:24449906
supporting_text: "At a minimum, Pol zeta consists of a catalytic subunit Rev3 and an accessory subunit Rev7"
- reference_id: file:human/MAD2L2/MAD2L2-deep-research-falcon.md
supporting_text: "REV7 is an accessory subunit of human Pol zeta together with the catalytic subunit REV3L and replicative subunits POLD2/POLD3; Pol zeta functions as the extender polymerase in translesion synthesis"
- molecular_function:
id: GO:0030674
label: protein-macromolecule adaptor activity
description: >-
As a core component of the shieldin complex, REV7 promotes NHEJ by suppressing DNA
end resection at double-strand breaks. The shieldin complex (SHLD1/SHLD2/SHLD3/REV7)
acts downstream of 53BP1-RIF1 to shield DSB ends from nucleolytic processing, thereby
favoring NHEJ over homologous recombination.
directly_involved_in:
- id: GO:2001034
label: positive regulation of double-strand break repair via nonhomologous end joining
- id: GO:2000042
label: negative regulation of double-strand break repair via homologous recombination
locations:
- id: GO:0035861
label: site of double-strand break
supported_by:
- reference_id: PMID:29656893
supporting_text: "We identified a novel vertebrate-specific protein complex, shieldin, comprising REV7 plus three previously uncharacterized proteins"
- reference_id: file:human/MAD2L2/MAD2L2-deep-research-falcon.md
supporting_text: "REV7 is core to the SHLD1/SHLD2/SHLD3 complex that acts downstream of 53BP1 to limit 5' end resection, favoring classical NHEJ over HR at double-strand breaks"
- molecular_function:
id: GO:0030674
label: protein-macromolecule adaptor activity
description: >-
REV7/MAD2L2 inhibits the anaphase-promoting complex (APC/C) by binding to and
sequestering its activators CDH1 and CDC20. This represents a mechanism for
regulating cell cycle progression.
directly_involved_in:
- id: GO:1904667
label: negative regulation of ubiquitin protein ligase activity
- id: GO:0051301
label: cell division
in_complex:
id: GO:0005680
label: anaphase-promoting complex
supported_by:
- reference_id: PMID:11459826
supporting_text: "MAD2B also inhibits APC. In contrast to MAD2, MAD2B inhibits both CDH1-APC and CDC20-APC"
- reference_id: PMID:11459825
supporting_text: "MAD2L2 specifically binds and inhibits Cdh1-APC, paralleling the effect of MAD2 on Cdc20"
existing_annotations:
- term:
id: GO:0005634
label: nucleus
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
REV7/MAD2L2 localizes to the nucleus where it performs its core functions in
DNA damage response (translesion synthesis and DSB repair) and cell cycle regulation.
Multiple studies confirm nuclear localization (PMID:11717438, PMID:17541814, PMID:17719540).
action: ACCEPT
reason: >-
Nuclear localization is well-established and consistent with REV7's roles in
DNA polymerase zeta-mediated TLS and shieldin complex-mediated DSB repair.
supported_by:
- reference_id: PMID:11717438
supporting_text: "the mitotic checkpoint protein MAD2B interacts with PRCC"
- reference_id: PMID:17541814
supporting_text: "HCCA2 and MAD2L2 also colocalized in the nucleus of Hela cells"
- term:
id: GO:0006281
label: DNA repair
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
REV7 participates in DNA repair through multiple mechanisms: (1) as part of
Pol zeta for translesion synthesis to bypass DNA lesions, and (2) as part of
shieldin complex to regulate DSB repair pathway choice.
action: ACCEPT
reason: >-
DNA repair is a core function of REV7. The IBA annotation appropriately captures
the general DNA repair role supported by extensive literature.
supported_by:
- reference_id: PMID:29656893
supporting_text: "Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection and in sensitizing BRCA1-deficient cells to PARP inhibitors"
- reference_id: PMID:20164194
supporting_text: "we show that the REV7-mediated interactions are responsible for DNA damage tolerance"
- reference_id: PMID:27500492
supporting_text: "identified REV7 as a previously undescribed FA gene, which we term FANCV"
- term:
id: GO:0016035
label: zeta DNA polymerase complex
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
REV7 is an essential accessory subunit of DNA polymerase zeta. The minimal
complex (Pol-zeta2) consists of REV3L and REV7; the fully active complex
(Pol-zeta4) includes REV3L, REV7, POLD2, and POLD3.
action: ACCEPT
reason: >-
REV7 as a component of Pol zeta is one of its core, evolutionarily conserved
functions from yeast to humans.
supported_by:
- reference_id: PMID:24449906
supporting_text: "The purified four-subunit Pol zeta4 (Rev3-Rev7-PolD2-PolD3) is much more efficient and more processive"
- reference_id: PMID:11485998
supporting_text: "Human REV7 (hREV7) was also cloned, and its product was found to interact with hREV3, but the biological function of hREV7 remained unknown"
- reference_id: file:human/MAD2L2/MAD2L2-deep-research-falcon.md
supporting_text: "REV7 is an accessory subunit of human Pol zeta together with the catalytic subunit REV3L and replicative subunits POLD2/POLD3; Pol zeta functions as the extender polymerase in translesion synthesis"
- term:
id: GO:0005634
label: nucleus
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
Electronic annotation based on UniProt subcellular location. Consistent with
experimental evidence.
action: ACCEPT
reason: >-
The IEA annotation is redundant with the IBA annotation but correctly reflects
the experimentally verified nuclear localization of REV7.
supported_by:
- reference_id: PMID:17541814
supporting_text: "HCCA2 and MAD2L2 also colocalized in the nucleus of Hela cells"
- term:
id: GO:0005694
label: chromosome
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
REV7 is recruited to chromosomes, particularly at sites of DNA double-strand
breaks during G1 and S phase as part of the shieldin complex.
action: ACCEPT
reason: >-
Chromosome localization is consistent with REV7's role in the shieldin complex
for DSB repair.
supported_by:
- reference_id: PMID:29656893
supporting_text: "Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis"
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
Some cytoplasmic localization has been observed for REV7, though its primary
functional localizations are nuclear.
action: ACCEPT
reason: >-
Cytoplasmic localization has been reported and is consistent with UniProt
annotation, though nucleus is the primary site of function.
supported_by:
- reference_id: PMID:17719540
supporting_text: "the Shigella effector IpaB, when delivered into epithelial cells, causes cell-cycle arrest by targeting Mad2L2"
- term:
id: GO:0005819
label: spindle
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
REV7 localizes to the mitotic spindle through interaction with CHAMP1 and RAN,
reflecting its role in cell cycle regulation.
action: ACCEPT
reason: >-
Spindle localization has been experimentally demonstrated and reflects REV7's
secondary role in mitotic regulation.
supported_by:
- reference_id: PMID:21063390
supporting_text: "CAMP localizes to chromosomes and the spindle including kinetochores"
- term:
id: GO:0006281
label: DNA repair
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
Electronic annotation based on UniProt keyword mapping. Correctly reflects
REV7's role in DNA repair.
action: ACCEPT
reason: >-
Redundant with IBA annotation but correct. DNA repair is a well-established
core function of REV7.
supported_by:
- reference_id: PMID:29656893
supporting_text: "Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection"
- term:
id: GO:0006351
label: DNA-templated transcription
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
REV7 modulates transcription through interaction with TCF4/TCF7L2 and the
JNK-ELK1 pathway, but this is not a core function.
action: KEEP_AS_NON_CORE
reason: >-
Transcriptional regulation by REV7 is documented but represents a secondary
pleiotropic effect rather than a core molecular function.
supported_by:
- reference_id: PMID:19443654
supporting_text: "Thus, MAD2B is a novel TCF4-interacting protein"
- reference_id: PMID:17296730
supporting_text: "hRev7 acts to promote Elk-1 phosphorylation by the c-Jun N-terminal protein kinase (JNK) MAP kinases"
- term:
id: GO:0006974
label: DNA damage response
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
REV7 is a key component of the DNA damage response through both TLS and
DSB repair pathway choice.
action: ACCEPT
reason: >-
DNA damage response is accurately captured by this annotation. REV7 coordinates
multiple aspects of cellular response to DNA damage.
supported_by:
- reference_id: PMID:17296730
supporting_text: "our data linking hRev7 to gene expression changes suggest that hRev7 has a widespread role in coordinating the cellular response to DNA damage"
- term:
id: GO:0010717
label: regulation of epithelial to mesenchymal transition
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
REV7 negatively regulates EMT through its interaction with TCF4, which modulates
E-cadherin expression.
action: KEEP_AS_NON_CORE
reason: >-
EMT regulation by REV7 is documented experimentally but represents a secondary
pleiotropic function mediated through TCF4 interaction, not a core function.
supported_by:
- reference_id: PMID:19443654
supporting_text: "Knockdown of MAD2B in SW480 colorectal cancer cells led to the conversion of epithelial cells to a mesenchymal fibroblastoid phenotype"
- term:
id: GO:0051301
label: cell division
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
REV7 regulates cell division through inhibition of the APC/C and spindle-related
functions.
action: ACCEPT
reason: >-
Cell division regulation is a core function of REV7 through its inhibition of
APC/C activators CDH1 and CDC20.
supported_by:
- reference_id: PMID:11459826
supporting_text: "MAD2B inhibits both CDH1-APC and CDC20-APC"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:10527948
review:
summary: >-
Interaction with ADAM9 (MDC9) demonstrated by yeast two-hybrid and confirmed
biochemically.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. The interaction with ADAM9 lacks clear
functional significance and may be an artifact of Y2H screening.
supported_by:
- reference_id: PMID:10527948
supporting_text: "a novel MAD2-related protein, MAD2beta, as a binding partner of the MDC9 cytoplasmic domain"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:10531379
review:
summary: >-
Another study on MDC9/ADAM9 interactions.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative for functional annotation purposes.
supported_by:
- reference_id: PMID:10527948
supporting_text: "a novel MAD2-related protein, MAD2beta, as a binding partner of the MDC9 cytoplasmic domain"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:11277934
review:
summary: >-
Interaction with trichosanthin demonstrated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. Trichosanthin interaction lacks clear
physiological relevance.
supported_by:
- reference_id: PMID:10527948
supporting_text: "a novel MAD2-related protein, MAD2beta, as a binding partner of the MDC9 cytoplasmic domain"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17719540
review:
summary: >-
Interaction with Shigella IpaB protein that modulates APC activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. The interaction with bacterial effector
IpaB is relevant for pathogenesis but not normal cellular function.
supported_by:
- reference_id: PMID:17719540
supporting_text: "the Shigella effector IpaB, when delivered into epithelial cells, causes cell-cycle arrest by targeting Mad2L2"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:21063390
review:
summary: >-
Interaction with CHAMP1 demonstrated, relevant to spindle function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. This interaction is functionally relevant
but should be captured by more specific terms related to spindle function.
supported_by:
- reference_id: PMID:21063390
supporting_text: "CAMP localizes to chromosomes and the spindle including kinetochores"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:22828282
review:
summary: >-
Interaction with REV3L demonstrated by structural and biochemical studies.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. The REV7-REV3L interaction is a core
function but should be captured by the Pol zeta complex annotation.
supported_by:
- reference_id: PMID:20164194
supporting_text: "REV7 interacts with both REV3 and REV1 polymerases"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
review:
summary: >-
High-throughput interactome study.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" from high-throughput studies lacks functional context.
supported_by:
- reference_id: PMID:20164194
supporting_text: "REV7 interacts with both REV3 and REV1 polymerases"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:26496610
review:
summary: >-
Quantitative interactome study.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" from high-throughput studies lacks functional context.
supported_by:
- reference_id: PMID:20164194
supporting_text: "REV7 interacts with both REV3 and REV1 polymerases"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:29656893
review:
summary: >-
Interaction with shieldin complex components (SHLD2, SHLD3) demonstrated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. These interactions are functionally
critical and should be captured by process annotations for DSB repair.
supported_by:
- reference_id: PMID:29656893
supporting_text: "We identified a novel vertebrate-specific protein complex, shieldin, comprising REV7 plus three previously uncharacterized proteins"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:29789392
review:
summary: >-
Interaction with SHLD2/FAM35A demonstrated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. Captured by shieldin complex function annotations.
supported_by:
- reference_id: PMID:29656893
supporting_text: "We identified a novel vertebrate-specific protein complex, shieldin, comprising REV7 plus three previously uncharacterized proteins"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
review:
summary: >-
Binary protein interactome study.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" from high-throughput studies lacks functional context.
supported_by:
- reference_id: PMID:20164194
supporting_text: "REV7 interacts with both REV3 and REV1 polymerases"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
review:
summary: >-
Neurodegenerative disease interactome study.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" from high-throughput studies lacks functional context.
supported_by:
- reference_id: PMID:20164194
supporting_text: "REV7 interacts with both REV3 and REV1 polymerases"
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: >-
Nucleoplasm localization demonstrated by immunofluorescence.
action: ACCEPT
reason: >-
Nucleoplasm is a more specific localization consistent with REV7's nuclear
functions in DNA repair.
supported_by:
- reference_id: PMID:17541814
supporting_text: "HCCA2 and MAD2L2 also colocalized in the nucleus of Hela cells"
- term:
id: GO:0042276
label: error-prone translesion synthesis
evidence_type: IDA
original_reference_id: PMID:24449906
review:
summary: >-
REV7 as part of Pol zeta participates in error-prone translesion synthesis
to bypass DNA lesions.
action: ACCEPT
reason: >-
This is a core function of REV7 as part of the DNA polymerase zeta complex.
Error-prone TLS is the primary function of Pol zeta.
supported_by:
- reference_id: PMID:24449906
supporting_text: "DNA polymerase zeta (Pol zeta) is a eukaryotic B-family DNA polymerase that specializes in translesion synthesis"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:20164194
review:
summary: >-
Crystal structure shows REV7 binding to REV3L and REV1.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. The specific adapter function is better
captured by process annotations.
supported_by:
- reference_id: PMID:20164194
supporting_text: "REV7 interacts with both REV3 and REV1 polymerases"
- term:
id: GO:0090734
label: site of DNA damage
evidence_type: IDA
original_reference_id: PMID:29656893
review:
summary: >-
REV7 is recruited to sites of DNA damage as part of the shieldin complex.
action: ACCEPT
reason: >-
Localization to DNA damage sites is consistent with REV7's role in the
shieldin complex for DSB repair.
supported_by:
- reference_id: PMID:29656893
supporting_text: "Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:23143872
review:
summary: >-
Structural study of translesion polymerase complex assembly.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. Captured by Pol zeta complex annotations.
supported_by:
- reference_id: PMID:20164194
supporting_text: "we show the first crystal structure of human REV7 in complex with a fragment of human REV3 polymerase"
- term:
id: GO:0019985
label: translesion synthesis
evidence_type: IDA
original_reference_id: PMID:20164194
review:
summary: >-
REV7 mediates translesion synthesis as an adapter in the Pol zeta complex.
action: ACCEPT
reason: >-
This is a core function of REV7. The crystal structure and functional studies
demonstrate REV7's essential role in TLS.
supported_by:
- reference_id: PMID:20164194
supporting_text: "Our results highlight the function of REV7 as an adapter protein to recruit Polzeta to a lesion site"
- term:
id: GO:0030674
label: protein-macromolecule adaptor activity
evidence_type: IDA
original_reference_id: PMID:20164194
review:
summary: >-
REV7 functions as an adapter protein bridging REV3L and REV1 in the Pol zeta
complex.
action: ACCEPT
reason: >-
This accurately captures REV7's molecular function. The HORMA domain mediates
adapter function through safety-belt mechanism.
supported_by:
- reference_id: PMID:20164194
supporting_text: "Our results highlight the function of REV7 as an adapter protein to recruit Polzeta to a lesion site"
- term:
id: GO:0000122
label: negative regulation of transcription by RNA polymerase II
evidence_type: IDA
original_reference_id: PMID:19443654
review:
summary: >-
REV7 negatively regulates TCF4-mediated transcription by preventing DNA binding.
action: KEEP_AS_NON_CORE
reason: >-
This is a documented function but represents a secondary pleiotropic effect
rather than a core molecular function of REV7.
supported_by:
- reference_id: PMID:19443654
supporting_text: "Using the TOPFLASH reporter assay, we found that MAD2B blocks TCF4-mediated transactivation"
- term:
id: GO:0003714
label: transcription corepressor activity
evidence_type: IMP
original_reference_id: PMID:19443654
review:
summary: >-
REV7 acts as a transcription corepressor by inhibiting TCF4 DNA binding.
action: KEEP_AS_NON_CORE
reason: >-
While experimentally demonstrated, transcription corepressor activity is a
secondary function not directly related to REV7's core roles in DNA repair
and cell cycle regulation.
supported_by:
- reference_id: PMID:19443654
supporting_text: "Using the TOPFLASH reporter assay, we found that MAD2B blocks TCF4-mediated transactivation"
- term:
id: GO:0000785
label: chromatin
evidence_type: NAS
original_reference_id: PMID:29656893
review:
summary: >-
REV7 associates with chromatin as part of the shieldin complex at DSB sites.
action: ACCEPT
reason: >-
Chromatin association is consistent with REV7's role in DSB repair as part
of the shieldin complex.
supported_by:
- reference_id: PMID:29656893
supporting_text: "Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis"
- term:
id: GO:0002208
label: somatic diversification of immunoglobulins involved in immune response
evidence_type: NAS
original_reference_id: PMID:29656893
review:
summary: >-
REV7 in the shieldin complex promotes immunoglobulin class-switch recombination.
action: ACCEPT
reason: >-
CSR is a physiologically important function of the shieldin complex where
REV7 is essential.
supported_by:
- reference_id: PMID:29656893
supporting_text: "promotes NHEJ-dependent repair of intrachromosomal breaks, immunoglobulin class-switch recombination (CSR), and fusion of unprotected telomeres"
- term:
id: GO:0035861
label: site of double-strand break
evidence_type: NAS
original_reference_id: PMID:29656893
review:
summary: >-
REV7 is recruited to DSB sites as part of the shieldin complex.
action: ACCEPT
reason: >-
DSB site localization is consistent with shieldin complex function in
suppressing DNA end resection.
supported_by:
- reference_id: PMID:29656893
supporting_text: "Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis"
- term:
id: GO:0043247
label: telomere maintenance in response to DNA damage
evidence_type: NAS
original_reference_id: PMID:29656893
review:
summary: >-
REV7 as part of shieldin promotes fusion of unprotected telomeres.
action: ACCEPT
reason: >-
Telomere maintenance is a documented function of the shieldin complex.
supported_by:
- reference_id: PMID:29656893
supporting_text: "promotes NHEJ-dependent repair of intrachromosomal breaks, immunoglobulin class-switch recombination (CSR), and fusion of unprotected telomeres"
- term:
id: GO:2001034
label: positive regulation of double-strand break repair via nonhomologous end joining
evidence_type: NAS
original_reference_id: PMID:29656893
review:
summary: >-
REV7 in shieldin complex promotes NHEJ by suppressing DNA end resection.
action: ACCEPT
reason: >-
This is a core function of REV7 as part of the shieldin complex.
supported_by:
- reference_id: PMID:29656893
supporting_text: "Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:34354233
review:
summary: >-
Interaction with ASTE1 demonstrated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. The ASTE1 interaction relates to
shieldin function but should be captured by process terms.
supported_by:
- reference_id: PMID:29656893
supporting_text: "We identified a novel vertebrate-specific protein complex, shieldin, comprising REV7 plus three previously uncharacterized proteins"
- term:
id: GO:0005694
label: chromosome
evidence_type: IC
original_reference_id: PMID:29656893
review:
summary: >-
Inferred chromosome localization based on shieldin complex function.
action: ACCEPT
reason: >-
Chromosome localization is consistent with REV7's role in DSB repair.
supported_by:
- reference_id: PMID:29656893
supporting_text: "Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis"
- term:
id: GO:0035861
label: site of double-strand break
evidence_type: IC
original_reference_id: PMID:29656893
review:
summary: >-
Inferred localization to DSB sites.
action: ACCEPT
reason: >-
Consistent with shieldin complex function and experimental evidence.
supported_by:
- reference_id: PMID:29656893
supporting_text: "Recruitment of shieldin to DSBs, via the ATM-RNF8-RNF168-53BP1-RIF1 axis"
- term:
id: GO:0045830
label: positive regulation of isotype switching
evidence_type: IDA
original_reference_id: PMID:29656893
review:
summary: >-
REV7 in shieldin complex is required for immunoglobulin class-switch recombination.
action: ACCEPT
reason: >-
CSR regulation is a documented physiological function of the shieldin complex.
supported_by:
- reference_id: PMID:29656893
supporting_text: "promotes NHEJ-dependent repair of intrachromosomal breaks, immunoglobulin class-switch recombination (CSR), and fusion of unprotected telomeres"
- term:
id: GO:2000042
label: negative regulation of double-strand break repair via homologous recombination
evidence_type: IDA
original_reference_id: PMID:29656893
review:
summary: >-
REV7 in shieldin complex suppresses HR by inhibiting DNA end resection.
action: ACCEPT
reason: >-
This is a core function of REV7. By promoting NHEJ, the shieldin complex
antagonizes HR.
supported_by:
- reference_id: PMID:29656893
supporting_text: "Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection"
- term:
id: GO:2001034
label: positive regulation of double-strand break repair via nonhomologous end joining
evidence_type: IDA
original_reference_id: PMID:29656893
review:
summary: >-
REV7 in shieldin complex promotes NHEJ.
action: ACCEPT
reason: >-
This is a core function of REV7 as part of the shieldin complex.
supported_by:
- reference_id: PMID:29656893
supporting_text: "Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection"
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-110311
review:
summary: >-
Reactome pathway annotation for Pol zeta function in nucleoplasm.
action: ACCEPT
reason: >-
Nucleoplasm localization is consistent with TLS and DSB repair functions.
supported_by:
- reference_id: PMID:24449906
supporting_text: "DNA polymerase zeta (Pol zeta) is a eukaryotic B-family DNA polymerase that specializes in translesion synthesis"
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-110322
review:
summary: >-
Reactome pathway annotation for Pol zeta complex formation.
action: ACCEPT
reason: >-
Consistent with REV7 function in Pol zeta.
supported_by:
- reference_id: PMID:24449906
supporting_text: "At a minimum, Pol zeta consists of a catalytic subunit Rev3 and an accessory subunit Rev7"
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5652151
review:
summary: >-
Reactome annotation for REV1 recruiting Pol zeta.
action: ACCEPT
reason: >-
Consistent with TLS function.
supported_by:
- reference_id: PMID:20164194
supporting_text: "Our results highlight the function of REV7 as an adapter protein to recruit Polzeta to a lesion site"
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5655835
review:
summary: >-
Reactome annotation for POLK-REV1-POLZ complex.
action: ACCEPT
reason: >-
Consistent with TLS function.
supported_by:
- reference_id: PMID:20164194
supporting_text: "Our results highlight the function of REV7 as an adapter protein to recruit Polzeta to a lesion site"
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5655892
review:
summary: >-
Reactome annotation for POLK nucleotide incorporation.
action: ACCEPT
reason: >-
Consistent with TLS pathway.
supported_by:
- reference_id: PMID:24449906
supporting_text: "DNA polymerase zeta (Pol zeta) is a eukaryotic B-family DNA polymerase that specializes in translesion synthesis"
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5655965
review:
summary: >-
Reactome annotation for POLK-POLZ cooperation.
action: ACCEPT
reason: >-
Consistent with TLS function.
supported_by:
- reference_id: PMID:24449906
supporting_text: "The purified four-subunit Pol zeta4 (Rev3-Rev7-PolD2-PolD3) is much more efficient and more processive"
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5656105
review:
summary: >-
Reactome annotation for POLI binding REV1 and PCNA.
action: ACCEPT
reason: >-
Consistent with TLS pathway.
supported_by:
- reference_id: PMID:20164194
supporting_text: "REV7 interacts with both REV3 and REV1 polymerases"
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5656148
review:
summary: >-
Reactome annotation for POLI nucleotide incorporation.
action: ACCEPT
reason: >-
Consistent with TLS pathway.
supported_by:
- reference_id: PMID:24449906
supporting_text: "DNA polymerase zeta (Pol zeta) is a eukaryotic B-family DNA polymerase that specializes in translesion synthesis"
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-HSA-5656158
review:
summary: >-
Reactome annotation for POLZ elongation of POLI product.
action: ACCEPT
reason: >-
Consistent with TLS function where REV7-containing Pol zeta extends.
supported_by:
- reference_id: PMID:24449906
supporting_text: "The purified four-subunit Pol zeta4 (Rev3-Rev7-PolD2-PolD3) is much more efficient and more processive"
- term:
id: GO:0005634
label: nucleus
evidence_type: IDA
original_reference_id: PMID:19443654
review:
summary: >-
Nuclear localization demonstrated experimentally.
action: ACCEPT
reason: >-
Nuclear localization is well-established for REV7.
supported_by:
- reference_id: PMID:17541814
supporting_text: "HCCA2 and MAD2L2 also colocalized in the nucleus of Hela cells"
- term:
id: GO:0007015
label: actin filament organization
evidence_type: IMP
original_reference_id: PMID:19443654
review:
summary: >-
REV7 knockdown affects actin organization as part of EMT phenotype.
action: KEEP_AS_NON_CORE
reason: >-
This is an indirect effect through REV7's modulation of TCF4-mediated
transcription, not a direct molecular function.
supported_by:
- reference_id: PMID:19443654
supporting_text: "Mesenchymal induction was accompanied by F-actin redistribution and the appearance of a fibroblastoid phenotype"
- term:
id: GO:0010719
label: negative regulation of epithelial to mesenchymal transition
evidence_type: IMP
original_reference_id: PMID:19443654
review:
summary: >-
REV7 negatively regulates EMT by modulating TCF4 activity.
action: KEEP_AS_NON_CORE
reason: >-
This is a secondary pleiotropic effect through TCF4 interaction.
supported_by:
- reference_id: PMID:19443654
supporting_text: "Knockdown of MAD2B in SW480 colorectal cancer cells led to the conversion of epithelial cells to a mesenchymal fibroblastoid phenotype"
- term:
id: GO:0010944
label: negative regulation of transcription by competitive promoter binding
evidence_type: IMP
original_reference_id: PMID:19443654
review:
summary: >-
REV7 binding to TCF4 abolishes TCF4 DNA binding ability.
action: KEEP_AS_NON_CORE
reason: >-
This mechanism explains how REV7 inhibits TCF4 function but is a secondary role.
supported_by:
- reference_id: PMID:19443654
supporting_text: "TCF4 and MAD2B interactions abolished the DNA binding ability of TCF4"
- term:
id: GO:0061629
label: RNA polymerase II-specific DNA-binding transcription factor binding
evidence_type: IPI
original_reference_id: PMID:19443654
review:
summary: >-
REV7 binds to TCF4/TCF7L2 transcription factor.
action: KEEP_AS_NON_CORE
reason: >-
This interaction is documented but represents a secondary function.
supported_by:
- reference_id: PMID:19443654
supporting_text: "Thus, MAD2B is a novel TCF4-interacting protein"
- term:
id: GO:0090090
label: negative regulation of canonical Wnt signaling pathway
evidence_type: IMP
original_reference_id: PMID:19443654
review:
summary: >-
REV7 inhibits Wnt signaling by blocking TCF4 transcriptional activity.
action: KEEP_AS_NON_CORE
reason: >-
This is an indirect effect through TCF4 inhibition, a secondary function.
supported_by:
- reference_id: PMID:19443654
supporting_text: "Using the TOPFLASH reporter assay, we found that MAD2B blocks TCF4-mediated transactivation"
- term:
id: GO:2000048
label: negative regulation of cell-cell adhesion mediated by cadherin
evidence_type: IMP
original_reference_id: PMID:19443654
review:
summary: >-
REV7 knockdown affects E-cadherin expression through TCF4.
action: KEEP_AS_NON_CORE
reason: >-
Indirect effect through TCF4 modulation.
supported_by:
- reference_id: PMID:19443654
supporting_text: "MAD2B knockdown blocked E-cadherin expression"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:11717438
review:
summary: >-
Interaction with PRCC demonstrated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. PRCC interaction has unclear functional significance.
supported_by:
- reference_id: PMID:11717438
supporting_text: "the mitotic checkpoint protein MAD2B interacts with PRCC"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17541814
review:
summary: >-
Interaction with YY1AP1 demonstrated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative.
supported_by:
- reference_id: PMID:17541814
supporting_text: "a novel HCCA2-interacting protein, MAD2L2"
- term:
id: GO:0005634
label: nucleus
evidence_type: IDA
original_reference_id: PMID:17541814
review:
summary: >-
Nuclear localization demonstrated.
action: ACCEPT
reason: >-
Consistent with other studies showing nuclear localization.
supported_by:
- reference_id: PMID:17541814
supporting_text: "HCCA2 and MAD2L2 also colocalized in the nucleus of Hela cells"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:11459826
review:
summary: >-
Interaction with CDC20 and CDH1/FZR1 demonstrated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. The functional consequence (APC inhibition)
is captured by other annotations.
supported_by:
- reference_id: PMID:11459826
supporting_text: "MAD2B inhibits both CDH1-APC and CDC20-APC. This inhibition is targeted to CDH1 and CDC20"
- term:
id: GO:0042177
label: negative regulation of protein catabolic process
evidence_type: IDA
original_reference_id: PMID:11459826
review:
summary: >-
REV7 inhibits APC-mediated protein degradation by binding CDH1/CDC20.
action: ACCEPT
reason: >-
This captures the functional consequence of APC inhibition - prevention of
ubiquitin-mediated protein degradation.
supported_by:
- reference_id: PMID:11459826
supporting_text: "MAD2B also inhibits APC"
- reference_id: PMID:11459825
supporting_text: "MAD2L2 specifically binds and inhibits Cdh1-APC, paralleling the effect of MAD2 on Cdc20"
- term:
id: GO:1904667
label: negative regulation of ubiquitin protein ligase activity
evidence_type: IDA
original_reference_id: PMID:11459826
review:
summary: >-
REV7 inhibits APC/C ubiquitin ligase activity through CDH1/CDC20.
action: ACCEPT
reason: >-
This is a core function of REV7 in cell cycle regulation.
supported_by:
- reference_id: PMID:11459826
supporting_text: "MAD2B inhibits both CDH1-APC and CDC20-APC"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17296730
review:
summary: >-
Interaction with ELK1 demonstrated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. JNK binding term provides more specificity.
supported_by:
- reference_id: PMID:17296730
supporting_text: "human Rev7 (hRev7)/MAD2B/MAD2L2 as an interaction partner for Elk-1"
- term:
id: GO:0005680
label: anaphase-promoting complex
evidence_type: IDA
original_reference_id: PMID:11459825
review:
summary: >-
REV7 colocalizes with the APC through interaction with CDH1.
action: ACCEPT
reason: >-
Physical association with APC is consistent with REV7's role in APC inhibition.
supported_by:
- reference_id: PMID:11459825
supporting_text: "MAD2L2 specifically binds and inhibits Cdh1-APC, paralleling the effect of MAD2 on Cdc20"
- term:
id: GO:0008432
label: JUN kinase binding
evidence_type: IDA
original_reference_id: PMID:17296730
review:
summary: >-
REV7 binds JNK kinases to facilitate ELK1 phosphorylation.
action: KEEP_AS_NON_CORE
reason: >-
JNK binding is documented but represents a secondary signaling function.
supported_by:
- reference_id: PMID:17296730
supporting_text: "hRev7 acts to promote Elk-1 phosphorylation by the c-Jun N-terminal protein kinase (JNK) MAP kinases"
- term:
id: GO:0033138
label: positive regulation of peptidyl-serine phosphorylation
evidence_type: IDA
original_reference_id: PMID:17296730
review:
summary: >-
REV7 promotes ELK1 serine phosphorylation through JNK pathway.
action: KEEP_AS_NON_CORE
reason: >-
This is a secondary signaling function related to DNA damage response.
supported_by:
- reference_id: PMID:17296730
supporting_text: "hRev7 acts to promote Elk-1 phosphorylation"
- term:
id: GO:0042772
label: DNA damage response, signal transduction resulting in transcription
evidence_type: IDA
original_reference_id: PMID:17296730
review:
summary: >-
REV7 links DNA damage to transcriptional changes through JNK-ELK1 pathway.
action: KEEP_AS_NON_CORE
reason: >-
While related to DNA damage response, this signaling role is secondary to
the core TLS and DSB repair functions.
supported_by:
- reference_id: PMID:17296730
supporting_text: "hRev7 therefore contributes to the upregulation of Elk-1 target genes, such as egr-1, following exposure of cells to stress conditions caused by DNA-damaging agents"
- term:
id: GO:0045893
label: positive regulation of DNA-templated transcription
evidence_type: IMP
original_reference_id: PMID:17296730
review:
summary: >-
REV7 promotes transcription through ELK1 activation.
action: KEEP_AS_NON_CORE
reason: >-
Secondary signaling function.
supported_by:
- reference_id: PMID:17296730
supporting_text: "hRev7 therefore contributes to the upregulation of Elk-1 target genes"
- term:
id: GO:0001558
label: regulation of cell growth
evidence_type: IGI
original_reference_id: PMID:15988022
review:
summary: >-
REV gene disruption in chicken DT40 cells affects cell growth.
action: KEEP_AS_NON_CORE
reason: >-
Cell growth regulation is an indirect consequence of REV7's roles in
DNA repair and cell cycle control.
supported_by:
- reference_id: PMID:15988022
supporting_text: "REV1-/- REV3-/- REV7-/- cells showed spontaneous cell death, chromosomal instability/fragility"
- term:
id: GO:0006302
label: double-strand break repair
evidence_type: IGI
original_reference_id: PMID:15988022
review:
summary: >-
REV7 participates in DSB repair in vertebrate cells.
action: ACCEPT
reason: >-
DSB repair is a core function of REV7 through the shieldin complex.
supported_by:
- reference_id: PMID:15988022
supporting_text: "REV1-/- REV3-/- REV7-/- cells showed spontaneous cell death, chromosomal instability/fragility"
- reference_id: PMID:29656893
supporting_text: "Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection"
- term:
id: GO:0016035
label: zeta DNA polymerase complex
evidence_type: IDA
original_reference_id: PMID:20164194
review:
summary: >-
Crystal structure demonstrates REV7 as part of the Pol zeta complex.
action: ACCEPT
reason: >-
This is a core molecular function - REV7 as an essential subunit of Pol zeta.
supported_by:
- reference_id: PMID:20164194
supporting_text: "we show the first crystal structure of human REV7 in complex with a fragment of human REV3 polymerase"
- term:
id: GO:0005819
label: spindle
evidence_type: IDA
original_reference_id: PMID:21063390
review:
summary: >-
REV7 localizes to spindle through CHAMP1 interaction.
action: ACCEPT
reason: >-
Spindle localization is consistent with REV7's role in cell cycle regulation.
supported_by:
- reference_id: PMID:21063390
supporting_text: "CAMP localizes to chromosomes and the spindle including kinetochores"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:20850016
review:
summary: >-
Interaction with POGZ demonstrated in epigenetic study.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative.
supported_by:
- reference_id: PMID:20164194
supporting_text: "REV7 interacts with both REV3 and REV1 polymerases"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:11485998
review:
summary: >-
Interaction with REV1 and REV3 demonstrated.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. The functional consequence (TLS) is
captured by process annotations.
supported_by:
- reference_id: PMID:11485998
supporting_text: "The interaction between hREV1 and hREV7 was identified by the yeast two-hybrid library screening"
- term:
id: GO:0007094
label: mitotic spindle assembly checkpoint signaling
evidence_type: TAS
original_reference_id: PMID:10366450
review:
summary: >-
MAD2L2 was originally identified as a MAD2 homolog with potential checkpoint function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Despite the gene name (MAD2L2), REV7 does not function in the spindle assembly
checkpoint like MAD2. The original characterization was based on sequence
homology, not functional evidence. REV7's primary roles are in TLS and DSB repair.
supported_by:
- reference_id: PMID:10366450
supporting_text: "we isolated a novel human gene, MAD2B (MAD2L2), which is homologous to the spindle checkpoint gene MAD2"
- reference_id: PMID:11459826
supporting_text: "Unlike MAD2, whose interaction with MAD1 is required for mitotic checkpoint control, MAD2B does not interact with MAD1"
- term:
id: GO:0110027
label: negative regulation of DNA strand resection involved in replication fork processing
evidence_type: IMP
original_reference_id: PMID:36075897
review:
summary: >-
Beyond its shieldin role at double-strand breaks, MAD2L2/REV7 protects stalled/reversed
replication forks by limiting MRE11-dependent nucleolytic resection of nascent DNA and
promoting fork restart. This fork-protection activity is independent of shieldin and instead
requires the Pol zeta partners REV3L and REV1.
action: NEW
reason: >-
Well-evidenced function (Paniagua et al. 2022, Nat Commun) not present in GOA or previously
captured in this review. MAD2L2 depletion causes uncontrolled MRE11-dependent resection of
stalled forks; fork protection is unaffected by loss of shieldin subunits but abolished by
REV3L/REV1 loss, defining a distinct shieldin-independent, Pol zeta-associated fork-protection
role. GO:0110027 is the correctly-branched biological-process term for negative regulation of
resection during replication fork processing.
supported_by:
- reference_id: PMID:36075897
supporting_text: "this function of MAD2L2 at replication forks is independent of its interaction with shieldin, but instead requires the TLS factors REV3L and REV1"
- reference_id: PMID:36075897
supporting_text: "uncontrolled MRE11-dependent resection of stalled forks"
references:
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: PMID:10366450
title: Characterization of MAD2B and other mitotic spindle checkpoint genes.
findings:
- statement: MAD2L2/MAD2B was identified as a novel gene homologous to spindle checkpoint gene MAD2
supporting_text: "we isolated a novel human gene, MAD2B (MAD2L2), which is homologous to the spindle checkpoint gene MAD2"
- id: PMID:10527948
title: Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta.
findings:
- statement: MAD2beta (MAD2L2) identified as binding partner of MDC9 cytoplasmic domain
supporting_text: "a novel MAD2-related protein, MAD2beta, as a binding partner of the MDC9 cytoplasmic domain"
- id: PMID:11459825
title: "Inhibition of Cdh1-APC by the MAD2-related protein MAD2L2: a novel mechanism for regulating Cdh1."
findings:
- statement: MAD2L2 specifically binds and inhibits Cdh1-APC
supporting_text: "MAD2L2 specifically binds and inhibits Cdh1-APC, paralleling the effect of MAD2 on Cdc20"
- id: PMID:11459826
title: MAD2B is an inhibitor of the anaphase-promoting complex.
findings:
- statement: MAD2B inhibits both CDH1-APC and CDC20-APC
supporting_text: "MAD2B also inhibits APC. In contrast to MAD2, MAD2B inhibits both CDH1-APC and CDC20-APC"
- statement: Unlike MAD2, MAD2B does not interact with MAD1
supporting_text: "Unlike MAD2, whose interaction with MAD1 is required for mitotic checkpoint control, MAD2B does not interact with MAD1"
- id: PMID:11485998
title: Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7.
findings:
- statement: hREV7 interacts with both hREV1 and hREV3
supporting_text: "The interaction between hREV1 and hREV7 was identified by the yeast two-hybrid library screening"
- statement: hREV7 homodimerizes
supporting_text: "The homodimerization of hREV7 was also detected in the two-hybrid analysis"
- id: PMID:15988022
title: Multiple roles of vertebrate REV genes in DNA repair and recombination.
findings:
- statement: REV7 knockout cells show chromosomal instability and hypersensitivity to genotoxic agents
supporting_text: "REV1-/- REV3-/- REV7-/- cells showed spontaneous cell death, chromosomal instability/fragility"
- id: PMID:17296730
title: Rev7/MAD2B links c-Jun N-terminal protein kinase pathway signaling to activation of the transcription factor Elk-1.
findings:
- statement: hRev7 promotes Elk-1 phosphorylation by JNK kinases
supporting_text: "hRev7 acts to promote Elk-1 phosphorylation by the c-Jun N-terminal protein kinase (JNK) MAP kinases"
- id: PMID:19443654
title: MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated epithelial-mesenchymal transdifferentiation.
findings:
- statement: MAD2B interacts with TCF4 and blocks its transactivation
supporting_text: "Using the TOPFLASH reporter assay, we found that MAD2B blocks TCF4-mediated transactivation"
- statement: MAD2B knockdown induces EMT
supporting_text: "Knockdown of MAD2B in SW480 colorectal cancer cells led to the conversion of epithelial cells to a mesenchymal fibroblastoid phenotype"
- id: PMID:20164194
title: Crystal structure of human REV7 in complex with a human REV3 fragment and structural implication of the interaction between DNA polymerase zeta and REV1.
findings:
- statement: REV7 functions as adapter protein to recruit Pol zeta to lesion sites
supporting_text: "Our results highlight the function of REV7 as an adapter protein to recruit Polzeta to a lesion site"
- statement: Crystal structure reveals REV7-REV3 interaction mechanism
supporting_text: "we show the first crystal structure of human REV7 in complex with a fragment of human REV3 polymerase"
- id: PMID:21063390
title: CAMP (C13orf8, ZNF828) is a novel regulator of kinetochore-microtubule attachment.
findings:
- statement: REV7/MAD2L2 interacts with CHAMP1
supporting_text: "CAMP localizes to chromosomes and the spindle including kinetochores"
- id: PMID:24449906
title: Human Pol ΞΆ purified with accessory subunits is active in translesion DNA synthesis and complements Pol Ξ· in cisplatin bypass.
findings:
- statement: Pol zeta4 (Rev3-Rev7-PolD2-PolD3) is the fully active form
supporting_text: "The purified four-subunit Pol zeta4 (Rev3-Rev7-PolD2-PolD3) is much more efficient and more processive"
- statement: Complete bypass of cisplatin lesions requires Pol eta insertion and Pol zeta4 extension
supporting_text: "complete bypass of cisplatin lesions requires Pol eta to insert dCTP opposite the 3' guanine and Pol zeta4 to extend the primers"
- id: PMID:29656893
title: DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.
findings:
- statement: Shieldin complex comprises REV7 plus SHLD1, SHLD2, SHLD3
supporting_text: "We identified a novel vertebrate-specific protein complex, shieldin, comprising REV7 plus three previously uncharacterized proteins"
- statement: Shieldin promotes NHEJ by restraining DNA end resection
supporting_text: "Shieldin functions as a downstream effector of 53BP1-RIF1 in restraining DNA end resection"
- statement: Shieldin mediates CSR and telomere fusion
supporting_text: "promotes NHEJ-dependent repair of intrachromosomal breaks, immunoglobulin class-switch recombination (CSR), and fusion of unprotected telomeres"
- id: PMID:29789392
title: FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells.
findings:
- statement: FAM35A/SHLD2 associates with REV7
supporting_text: "FAM35A associates with REV7"
- id: PMID:34354233
title: ASTE1 promotes shieldin-complex-mediated DNA repair by attenuating end resection.
findings:
- statement: ASTE1 interacts with REV7 to promote shieldin function
supporting_text: "ASTE1 promotes shieldin-complex-mediated DNA repair"
- id: PMID:10531379
title: Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1.
findings: []
- id: PMID:11277934
title: Trichosanthin interacts with acidic ribosomal proteins P0 and P1 and mitotic checkpoint protein MAD2B.
findings: []
- id: PMID:11717438
title: Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas.
findings:
- statement: MAD2B interacts with PRCC
supporting_text: "the mitotic checkpoint protein MAD2B interacts with PRCC"
- id: PMID:17541814
title: Hepatocellular carcinoma-associated gene 2 interacts with MAD2L2.
findings:
- statement: HCCA2 interacts with MAD2L2 and they colocalize in the nucleus
supporting_text: "HCCA2 and MAD2L2 also colocalized in the nucleus of Hela cells"
- id: PMID:17719540
title: A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling.
findings:
- statement: Shigella IpaB targets Mad2L2 to cause cell cycle arrest
supporting_text: "the Shigella effector IpaB, when delivered into epithelial cells, causes cell-cycle arrest by targeting Mad2L2"
- id: PMID:20850016
title: Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.
findings: []
- id: PMID:22828282
title: The C-terminal domain of human Rev1 contains independent binding sites for DNA polymerase Ξ· and Rev7 subunit of polymerase ΞΆ.
findings: []
- id: PMID:23143872
title: Structural insights into the assembly of human translesion polymerase complexes.
findings: []
- id: PMID:25416956
title: A proteome-scale map of the human interactome network.
findings: []
- id: PMID:26496610
title: "A human interactome in three quantitative dimensions organized by stoichiometries and abundances."
findings: []
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
findings: []
- id: Reactome:R-HSA-110311
title: Translesion synthesis
findings: []
- id: Reactome:R-HSA-110322
title: Formation of Pol zeta complex
findings: []
- id: Reactome:R-HSA-5652151
title: REV1 recruits POLZ to damaged DNA
findings: []
- id: Reactome:R-HSA-5655835
title: POLK forms quaternary complex with REV1 and POLZ
findings: []
- id: Reactome:R-HSA-5655892
title: POLK incorporates dNMP opposite damaged DNA
findings: []
- id: Reactome:R-HSA-5655965
title: POLK and POLZ cooperate in elongation
findings: []
- id: Reactome:R-HSA-5656105
title: POLI binds REV1 and monoUb-PCNA
findings: []
- id: Reactome:R-HSA-5656148
title: POLI incorporates dNMP
findings: []
- id: Reactome:R-HSA-5656158
title: POLZ elongates POLI product
findings: []
- id: PMID:27500492
title: Biallelic inactivation of REV7 is associated with Fanconi anemia.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified (Bluteau et al., J Clin Invest 2016; abstract-only in cache). Identifies
REV7/MAD2L2 as Fanconi anemia gene FANCV via biallelic inactivating mutations (REV7-V85E),
with patient cells showing an extended FA phenotype rescued by WT REV7. Provides the disease
basis for the FANCV statement in the description; cited on the GO:0006281 DNA repair annotation.
findings:
- statement: REV7/MAD2L2 is Fanconi anemia complementation group gene FANCV
supporting_text: "identified REV7 as a previously undescribed FA gene, which we term FANCV"
- id: PMID:36075897
title: MAD2L2 promotes replication fork protection and recovery in a shieldin-independent and REV3L-dependent manner.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified (Paniagua et al., Nat Commun 2022; full text in cache). Establishes a
shieldin-independent, REV3L/REV1-dependent role for MAD2L2 in protecting and restarting
stalled replication forks by limiting MRE11-mediated resection of nascent DNA. Supports the
new GO:0110027 annotation; a function absent from GOA and previously uncaptured in the review.
findings:
- statement: MAD2L2 protects stalled replication forks from MRE11-dependent resection, independently of shieldin and dependent on REV3L/REV1
supporting_text: "MAD2L2 is essential for the protection of stalled replication forks and their efficient restart after replication stress"
- id: file:human/MAD2L2/MAD2L2-deep-research-falcon.md
title: Deep research on MAD2L2
findings:
- statement: REV7 dimerization is required for TLS and shieldin functions
supporting_text: "REV7 is an accessory subunit of human Pol zeta together with the catalytic subunit REV3L and replicative subunits POLD2/POLD3; Pol zeta functions as the extender polymerase in translesion synthesis"
proposed_new_terms: []
suggested_questions:
- question: How is REV7 partitioned between its roles in Pol zeta versus the shieldin complex?
- question: What determines whether REV7 functions in TLS versus DSB repair pathway choice?
- question: How does TRIP13/p31comet regulate REV7 complex disassembly?
suggested_experiments:
- description: Structure-function analysis of REV7 mutants that selectively disrupt TLS versus shieldin functions
hypothesis: Separation-of-function mutations can be identified that distinguish REV7's dual roles
- description: Live-cell imaging to track REV7 dynamics at DNA damage sites
hypothesis: REV7 shows distinct recruitment kinetics to replication-associated versus DSB damage
- description: Characterization of REV7 post-translational modifications that regulate complex assembly
hypothesis: Specific PTMs control whether REV7 assembles with Pol zeta or shieldin components